<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Oral lesions
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Oral lesions
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Oral lesions
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Giovanni Lodi, DDS, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert P Dellavalle, MD, PhD, MSPH
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Daniel G Deschler, MD, FACS
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Rosamaria Corona, MD, DSc
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Karen Law, MD, FACP
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Oct 04, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Diagnosing and treating mucosal lesions of the mouth and gums may be challenging for many clinicians because of the wide variety of conditions that can present with similar-appearing lesions. Moreover, most clinicians, other than dental professionals, receive inadequate training in the evaluation and management of oral diseases [
         <a href="#rid1">
          1
         </a>
         ]. As an example, in a study including hospital-based internists, over 80 percent of those surveyed felt that it was important to examine older patients' mouths, although less than 20 percent routinely performed such examinations [
         <a href="#rid2">
          2
         </a>
         ]. Further, the majority were not confident in their examination skills.
        </p>
        <p>
         This review will discuss the presentation and diagnosis of many types of oral lesions, including benign and malignant neoplasms, potentially malignant disorders, infections, ulcerations, hyperpigmentation, as well as normal variants that are important to recognize and identify. Detailed discussion of specific conditions, including oral leukoplakia, cheilitis, oral toxicities associated with chemotherapy, gingivitis, periodontal disease, odontogenic infections, halitosis, and burning mouth syndrome, are discussed separately. Oral cancers are also discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/118618.html" rel="external">
          "Oral leukoplakia"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/13654.html" rel="external">
          "Cheilitis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/119010.html" rel="external">
          "Actinic cheilitis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1152.html" rel="external">
          "Oral toxicity associated with systemic anticancer therapy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6858.html" rel="external">
          "Overview of gingivitis and periodontitis in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6280.html" rel="external">
          "Gingivitis and periodontitis in children and adolescents"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6282.html" rel="external">
          "Soft tissue lesions of the oral cavity in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3417.html" rel="external">
          "Epidemiology, pathogenesis, and clinical manifestations of odontogenic infections"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6843.html" rel="external">
          "Bad breath"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3355.html" rel="external">
          "Overview of craniofacial pain", section on 'Burning mouth syndrome'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3390.html" rel="external">
          "Epidemiology and risk factors for head and neck cancer"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3393.html" rel="external">
          "Overview of the diagnosis and staging of head and neck cancer"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3391.html" rel="external">
          "Chemoprevention and screening in oral dysplasia and squamous cell head and neck cancer"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3378.html" rel="external">
          "Epidemiology, staging, and clinical presentation of human papillomavirus associated head and neck cancer"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H472414340">
         <span class="h1">
          ORAL ANATOMY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The mouth is a complex anatomical space demarcated by specific structures  (
         <a class="graphic graphic_figure graphicRef69766 graphicRef54845" href="/z/d/graphic/69766.html" rel="external">
          figure 1A-B
         </a>
         ) and is comprised of two distinct areas, the vestibule and the oral cavity:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Vestibule
         </strong>
         – The vestibule is delineated by the inner aspect of the lips anteriorly, the inner cheek (buccal mucosa) laterally, and the labial and buccal aspects of the teeth and the gingivae of the alveolar processes medially  (
         <a class="graphic graphic_figure graphicRef129154" href="/z/d/graphic/129154.html" rel="external">
          figure 1C
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Oral cavity
         </strong>
         – The oral cavity is demarcated by the inner (oral) gingivae of the maxillary and mandibular alveolar processes anteriorly, the roof (the hard and soft palates) superiorly, and the floor of the mouth and the anterior two-thirds of the tongue inferiorly. The posterior boundary of the oral cavity is defined by the palatoglossal arch.
        </p>
        <p>
        </p>
        <p>
         The majority of the oral mucosa is a stratified, squamous, nonkeratinized mucosa and lines the inner lips, cheeks, much of the soft palate, floor of the mouth, ventral surface of the tongue, and the mucosa of the alveolar processes. Keratinized mucosa lines the remainder of the gingivae, the hard palate, and a portion of the soft palate. Specialized mucosa covers the dorsal and lateral aspects of the tongue.
        </p>
        <p class="headingAnchor" id="H1186482812">
         <span class="h1">
          INITIAL EVALUATION FOR ALL PATIENTS WITH ORAL LESIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although the United States Preventive Screening Task Force (USPSTF) determined that there is insufficient evidence to assess the balance of benefits and harms of screening for oral cancer in adults [
         <a href="#rid3">
          3
         </a>
         ], opportunistic screening (ie, that received by many patients from their primary care or dental providers during regular visits and treatments) may be a feasible and cost-effective option [
         <a href="#rid4">
          4,5
         </a>
         ]. In addition to an oral lesion discovered incidentally on such an examination, patients may present for evaluation of a lesion that they notice themselves.
        </p>
        <p>
         Although the clinician's examination of the oral lesion is critical in establishing the diagnosis, the historical and descriptive characteristics of the lesion provided by the patient (eg, location, duration, enlargement, associated pain) enhance the clinician's diagnostic accuracy. In addition, while oral lesions may arise independently of an association with another medical condition, they can also occur as a focal manifestation of a systemic condition. Further, the location of the lesion may give critical information as to the diagnosis (eg, some oral lesions only occur on the tongue due to the specialized mucosa not seen elsewhere within the mouth). (See
         <a class="local">
          'Tongue lesions'
         </a>
         below.)
        </p>
        <p>
         To establish an accurate differential diagnosis, we perform a focused clinical history and physical examination on all patients with oral lesions [
         <a href="#rid6">
          6-8
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical history
         </strong>
         – For all patients with an oral lesion, we perform a focused clinical history, with attention to:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Location of the lesion (eg, involvement of tongue only, all oral mucous membranes involved).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Color and quality of the lesion (eg, hyperpigmented, erythematous, white, bullous, erosive/ulcerated, macular versus papular).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Duration of time the lesion has been present (if noticed).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Change in the lesion (eg, change in color, enlargement, waxing and waning of lesion size, periodic recurrence with resolution in-between episodes).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Associated local symptoms (eg, bleeding, discharge, irritation, discomfort or pain, enlargement of local lymph nodes).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Systemic signs and symptoms (eg, fever, rash, arthralgias or arthritis, unintentional weight loss).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Medications, including any recent medication changes and the use of any intraoral (topical) preparations.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Tobacco use (including smoking and smokeless tobacco products), enquiring about current use and tobacco history. We also enquire about cannabis smoking.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In addition, we enquire about chewing betel quid, or "paan" (a combination of areca nut, spices, and tobacco that is popular in many parts of Asia).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Alcohol consumption, including current use and history of alcohol use.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Medical history, including any known autoimmune disease, malignancy (including history of previous hematopoietic cell transplant), immunosuppression (eg, infection with human immunodeficiency virus [HIV], active cancer treatment, immunosuppressive medication).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Dental work, including the use of dental appliances (eg, dentures) and the presence of amalgam fillings ("silver" fillings that contain elemental mercury).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Physical examination
         </strong>
         – In addition to the clinical history, we perform a careful intraoral and extraoral examination:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Intraoral examination
         </strong>
         – We perform both a tactile and visual inspection of the oral cavity using gloved hands under adequate illumination.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Before the examination, we ask patients to remove dental appliances (eg, dentures), although examination with the appliance in place can also provide useful information, particularly when a traumatic lesion is suspected.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         The oral lesion is carefully inspected with attention to the location, color, size, and quality (eg, pigmented, ulcerated) and palpated for texture (eg, soft versus indurated) and tenderness.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         We then systematically examine all oral structures in a consistent sequence. We use both hands, utilizing gauze to grasp the tongue during the examination in order to adequately visualize the entire oral cavity and vestibule  (
         <a class="graphic graphic_picture graphicRef118587" href="/z/d/graphic/118587.html" rel="external">
          picture 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Extraoral examination
         </strong>
         – For all patients with oral lesions, in addition to a thorough intraoral examination, we perform a focused examination of the perioral area, including:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Visual inspection of the lips and skin of the face and neck
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Observation for any asymmetry, swelling, or masses of the face or neck
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Palpation of head and neck lymph nodes, with particular attention to the anterior and posterior cervical, pre- and postauricular, submandibular, submental, parotid, and buccal lymph nodes
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2996362514">
         <span class="h1">
          NORMAL VARIANTS OF ORAL MUCOSA
         </span>
         <span class="headingEndMark">
          —
         </span>
         It is important to recognize that several apparent mucosal "abnormalities," such as leukoedema, Fordyce spots, and physiologic pigmentation, are actually normal variants and require no further evaluation or treatment.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3404012036">
         <span class="h2">
          Leukoedema
         </span>
         <span class="headingEndMark">
          —
         </span>
         Leukoedema is a benign mucosal change [
         <a href="#rid9">
          9
         </a>
         ], which presents as an asymptomatic, bilateral, grayish-white, semitransparent mucosal alteration that typically disappears if the mucosa is stretched  (
         <a class="graphic graphic_picture graphicRef86890" href="/z/d/graphic/86890.html" rel="external">
          picture 2
         </a>
         ). Leukoedema is thought to be caused by accumulation of fluid within epithelial cells of the buccal mucosa.
        </p>
        <p>
         Leukoedema is a common condition. In a cross-sectional study in the United States, the prevalence of leukoedema was variable (between 1 and 90 percent); it is also more prevalent among African-American individuals [
         <a href="#rid10">
          10,11
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1552117938">
         <span class="h2">
          Fordyce granules
         </span>
         <span class="headingEndMark">
          —
         </span>
         Fordyce granules or Fordyce spots represent ectopic sebaceous glands. They appear as white to yellow, 1 to 2 mm, discrete papules, symmetrically distributed on the buccal mucosa and vermilion border of the lips  (
         <a class="graphic graphic_picture graphicRef130079 graphicRef69406 graphicRef66778" href="/z/d/graphic/130079.html" rel="external">
          picture 3A-C
         </a>
         ). They are extremely common, found in up to 90 percent of the adult population [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3013948074">
         <span class="h2">
          Physiologic oral pigmentation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Physiologic oral pigmentation is commonly seen in individuals with darker skin types and results from increased melanocyte activity and melanin production [
         <a href="#rid12">
          12-14
         </a>
         ]. The pigmentation presents as a brown-gray band on the attached gingiva and is typically bilateral  (
         <a class="graphic graphic_picture graphicRef118581" href="/z/d/graphic/118581.html" rel="external">
          picture 4
         </a>
         ). Pigmented patches can also be seen on the hard palate, mouth floor, or buccal mucosa.
        </p>
        <p class="headingAnchor" id="H3402619431">
         <span class="h1">
          WHITE AND RED ORAL LESIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         White or red oral lesions include benign lesions (eg, morsicatio buccarum and frictional keratosis, white sponge nevus [WSN]), potentially malignant disorders (eg, erythroplakia, leukoplakia, oral lichen planus and other lichenoid lesions, submucous fibrosis, actinic cheilitis, chronic graft-versus-host disease [GVHD], oral lupus erythematosus [OLE]), malignant lesions (eg, squamous cell carcinoma [SCC]), and infections (eg, candidiasis, oral hairy leukoplakia).
        </p>
        <p class="headingAnchor" id="H380360853">
         <span class="h2">
          Morsicatio buccarum and frictional keratosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Morsicatio buccarum or morsicatio mucosae oris is a common lesion due to habitual cheek biting or tongue biting that presents as a macerated, white, thickened plaque with whitish fragments of epithelium that can be partially removed. These lesions are typically located in the proximity of the occlusal surfaces of the dentition  (
         <a class="graphic graphic_picture graphicRef118299 graphicRef118584" href="/z/d/graphic/118299.html" rel="external">
          picture 5A-B
         </a>
         ) [
         <a href="#rid9">
          9,15
         </a>
         ].
        </p>
        <p>
         Frictional keratosis is a white lesion that cannot be removed and typically develops on areas subject to chronic trauma, such as the retromolar pads and the edentulous alveolar ridge underneath ill-fitting dentures (benign alveolar ridge keratosis [BARK])  (
         <a class="graphic graphic_picture graphicRef130080 graphicRef119587" href="/z/d/graphic/130080.html" rel="external">
          picture 6A-B
         </a>
         ) [
         <a href="#rid16">
          16,17
         </a>
         ].
        </p>
        <p>
         Although frictional keratosis may mimic leukoplakia in appearance, it has no malignant potential. Biopsy is unnecessary if the appearance and clinical history are consistent with the diagnosis. If biopsied, mucosal acanthosis and hyperparakeratosis without dysplasia will be seen on histopathologic examination [
         <a href="#rid15">
          15
         </a>
         ]. Avoidance of recurrent mucosal trauma is required for resolution of the oral lesion and to prevent recurrence.
        </p>
        <p class="headingAnchor" id="H1934615996">
         <span class="h2">
          Oral candidiasis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Oral candidiasis is a common, opportunistic infection caused by intraoral, commensal yeasts and presents in three main forms [
         <a href="#rid18">
          18
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pseudomembranous candidiasis (thrush)
         </strong>
         – Pseudomembranous candidiasis is the most common form of oral candidiasis  (
         <a class="graphic graphic_picture graphicRef130081 graphicRef130082 graphicRef82214 graphicRef61040" href="/z/d/graphic/130081.html" rel="external">
          picture 7A-D
         </a>
         ). It presents with confluent, white patches or plaques that are, in most cases, asymptomatic. Typically, these lesions can be wiped off with a gauze, exposing an erythematous base.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hyperplastic candidiasis
         </strong>
         – Hyperplastic candidiasis is a relatively uncommon form of oral candidiasis  (
         <a class="graphic graphic_picture graphicRef118922" href="/z/d/graphic/118922.html" rel="external">
          picture 10C
         </a>
         ). It presents with elevated, white plaques most often located at the labial commissure or on the dorsal aspect of the tongue. In contrast with pseudomembranous oral candidiasis, these hyperplastic lesions cannot be wiped off.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Erythematous oral candidiasis
         </strong>
         – Erythematous oral candidiasis includes denture stomatitis, chronic atrophic candidiasis, median rhomboid glossitis, angular cheilitis, and linear gingival erythema:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Denture stomatitis
         </strong>
         is typically found in patients using removable prostheses (eg, dentures) and is typically limited to the mucosa beneath a full or partial denture  (
         <a class="graphic graphic_picture graphicRef130083" href="/z/d/graphic/130083.html" rel="external">
          picture 8
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Chronic
         </strong>
         <strong>
          atrophic candidiasis
         </strong>
         presents with red patches localized mainly to the palate and dorsum of the tongue. The acute form is most often associated with use of antibiotics or inhaled corticosteroids and with HIV infection.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Median rhomboid glossitis
         </strong>
         presents as a red, depapillated, somewhat rhomboidal midline lesion on the dorsum of the tongue  (
         <a class="graphic graphic_picture graphicRef118243 graphicRef118244" href="/z/d/graphic/118243.html" rel="external">
          picture 9A-B
         </a>
         ). (See
         <a class="local">
          'Median rhomboid glossitis'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Angular cheilitis
         </strong>
         presents as inflammation of the skin and contiguous labial mucosa located at the lateral commissures of the mouth  (
         <a class="graphic graphic_picture graphicRef71723" href="/z/d/graphic/71723.html" rel="external">
          picture 10E
         </a>
         ). (See
         <a class="local">
          'Cheilitis'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/13654.html" rel="external">
          "Cheilitis", section on 'Angular cheilitis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Linear gingival erythema
         </strong>
         presents as a brightly inflamed and well-defined band of marginal gingiva  (
         <a class="graphic graphic_picture graphicRef62628 graphicRef89483" href="/z/d/graphic/62628.html" rel="external">
          picture 10A-B
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/6858.html" rel="external">
          "Overview of gingivitis and periodontitis in adults", section on 'Non-plaque-associated gingivitis and gingival disease'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6282.html" rel="external">
          "Soft tissue lesions of the oral cavity in children", section on 'HIV gingivitis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Oral candidiasis is most commonly seen in infants, older adults who wear dentures, patients treated with antibiotics, and patients with immunodeficiency, such as those treated with chemotherapy or radiation therapy and those with HIV infection [
         <a href="#rid18">
          18,19
         </a>
         ]. Patients with hyposalivation (eg, reduced salivary flow) and those using inhaled glucocorticoids are also at increased risk for
         <em>
          Candida
         </em>
         infection. (See
         <a class="medical medical_review" href="/z/d/html/2432.html" rel="external">
          "Oropharyngeal candidiasis in adults", section on 'Risk factors'
         </a>
         .)
        </p>
        <p>
         The diagnosis of oral candidiasis is generally clinical, based upon the medical history and physical examination, but can be confirmed if necessary by Gram stain, potassium hydroxide preparation, or fungal culture (see
         <a class="medical medical_review" href="/z/d/html/2432.html" rel="external">
          "Oropharyngeal candidiasis in adults", section on 'Diagnosis'
         </a>
         ). Recurrent, recalcitrant, or extensive disease warrants immune status evaluation, including testing for HIV infection.
        </p>
        <p>
         Topical therapy is usually effective, although relapses in immunosuppressed patients are common. Patients with dentures should be reminded to clean and disinfect their dentures carefully and frequently to reduce the likelihood of developing candidiasis [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
         Treatment for oral candidiasis is reviewed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2432.html" rel="external">
          "Oropharyngeal candidiasis in adults", section on 'Treatment'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1708905847">
         <span class="h2">
          Oral hairy leukoplakia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Oral hairy leukoplakia lesions are white, corrugated, painless plaques that, unlike
         <em>
          Candida
         </em>
         , cannot be scraped from the surface to which they adhere  (
         <a class="graphic graphic_picture graphicRef120641" href="/z/d/graphic/120641.html" rel="external">
          picture 11
         </a>
         ). They generally affect the lateral portions of the tongue, although the floor of the mouth, the palate, or the buccal mucosa may also be involved. Oral hairy leukoplakia is an Epstein-Barr virus-induced lesion that occurs almost entirely in patients infected with HIV, although it has also been reported in immunocompetent patients [
         <a href="#rid21">
          21
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8283.html" rel="external">
          "Clinical manifestations and treatment of Epstein-Barr virus infection", section on 'Oral hairy leukoplakia'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3187770664">
         <span class="h2">
          Oral squamous cell carcinoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Oral squamous cell carcinoma (SCC) represents the vast majority of cancers of the oral cavity.
        </p>
        <p>
         Although some tumors may arise in apparently normal mucosa, in most cases, oral SCC occurs in areas of abnormal mucosa, such as leukoplakia, erythroplakia, or lichen planus. (See
         <a class="local">
          'Oral potentially malignant disorders'
         </a>
         below.)
        </p>
        <p>
         Oral SCC may present as an ulcer, often with indurated margins, or as a mass that does not heal. Symptoms are variable, depending upon lesion location and extension  (
         <a class="graphic graphic_picture graphicRef81810 graphicRef59057 graphicRef74239" href="/z/d/graphic/81810.html" rel="external">
          picture 12A-C
         </a>
         ). The tongue, particularly the lateral and ventrolateral aspects, is the most common location, followed by the mouth floor and the buccal mucosa [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p>
         For an oral lesion of ≥3 weeks duration, the acronym RULE has been proposed as a practical clinical prediction rule for early detection of oral SCC [
         <a href="#rid23">
          23
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          R
         </strong>
         ed or red and white lesion
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          U
         </strong>
         lcer
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          L
         </strong>
         ump
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          E
         </strong>
         specially when in combination or if indurated (firm on palpation)
        </p>
        <p>
        </p>
        <p>
         Any lesions meeting these criteria should be regarded with suspicion and biopsied.
        </p>
        <p>
         Oral SCC is particularly common in some regions of the world, such as Southeast Asia, and affects males more frequently than females, with a ratio of approximately 2:1 [
         <a href="#rid24">
          24-27
         </a>
         ].
        </p>
        <p>
         The main modifiable risk factors for oral SCC are:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tobacco use (smoked and smokeless)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Areca nut use
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Alcohol consumption
        </p>
        <p>
        </p>
        <p>
         The combined effect of alcohol and tobacco is greater than multiplicative for oral cavity cancer [
         <a href="#rid28">
          28,29
         </a>
         ]. However, oral cancer has been increasingly observed among subjects without any of the known modifiable risk factors [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p>
         Although most oropharyngeal SCCs, particularly SCC arising at the tongue base and palatine tonsils, are associated with human papillomavirus (HPV) infection, specifically HPV-16, oral SCC is associated with HPV-16 in less than 10 percent of cases [
         <a href="#rid31">
          31-33
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3390.html" rel="external">
          "Epidemiology and risk factors for head and neck cancer"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3378.html" rel="external">
          "Epidemiology, staging, and clinical presentation of human papillomavirus associated head and neck cancer"
         </a>
         .)
        </p>
        <p>
         The diagnosis, staging, and management of oral SCC are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/3390.html" rel="external">
          "Epidemiology and risk factors for head and neck cancer"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3375.html" rel="external">
          "Pathology of head and neck neoplasms", section on 'Squamous cell carcinoma'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3393.html" rel="external">
          "Overview of the diagnosis and staging of head and neck cancer", section on 'Diagnosis and staging evaluation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3407.html" rel="external">
          "Treatment of stage I and II (early) head and neck cancer: The oral cavity"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1481034669">
         <span class="h2">
          Oral potentially malignant disorders
         </span>
         <span class="headingEndMark">
          —
         </span>
         According to the nomenclature and classification proposed by the World Health Organization Collaborating Centre for Oral Cancer and Precancer working group, oral potentially malignant disorders (OPMDs), previously called oral precancerous or premalignant disorders, include [
         <a href="#rid6">
          6,34-36
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Leukoplakia
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Proliferative verrucous leukoplakia (PVL)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Erythroplakia
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oral lichen planus and other lichenoid lesions
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oral submucous fibrosis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Actinic cheilitis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oral chronic GVHD
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         OLE
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dyskeratosis congenita
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Palatal lesions in reverse smokers
        </p>
        <p>
        </p>
        <p>
         The overall worldwide prevalence of OPMD has been estimated around 4.5 percent and is highest in South Asian, South American, and Caribbean populations, with males more frequently affected than females [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h3">
          Leukoplakia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Oral leukoplakia is a relatively common OPMD that presents as white patches of the oral mucosa  (
         <a class="graphic graphic_picture graphicRef81049 graphicRef130115 graphicRef72711 graphicRef130116 graphicRef60939 graphicRef130114" href="/z/d/graphic/81049.html" rel="external">
          picture 13A-F
         </a>
         ) [
         <a href="#rid36">
          36
         </a>
         ]. Although leukoplakia is in itself a benign and asymptomatic condition, some patients will eventually develop SCC. In a meta-analysis including 92 studies and nearly 18,000 patients with oral leukoplakia, the estimated annual malignant transformation rate for leukoplakia was 1.56 percent [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p>
         Leukoplakia should be differentiated from other white oral lesions that do not carry an increased risk of cancer  (
         <a class="graphic graphic_algorithm graphicRef118579" href="/z/d/graphic/118579.html" rel="external">
          algorithm 1
         </a>
         ).
        </p>
        <p>
         The evaluation and management of oral leukoplakia is discussed in greater detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/118618.html" rel="external">
          "Oral leukoplakia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H60611044">
         <span class="h3">
          Proliferative verrucous leukoplakia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Proliferative verrucous leukoplakia (PVL) is a rare, aggressive form of nonhomogeneous oral leukoplakia characterized by verrucous appearance, multifocality, slow growth, and a rate of malignant transformation of over 70 percent  (
         <a class="graphic graphic_picture graphicRef95480" href="/z/d/graphic/95480.html" rel="external">
          picture 14
         </a>
         ) [
         <a href="#rid39">
          39-41
         </a>
         ].
        </p>
        <p>
         Oral PVL is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/118618.html" rel="external">
          "Oral leukoplakia", section on 'Proliferative verrucous leukoplakia'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H378983350">
         <span class="h3">
          Erythroplakia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Erythroplakia is an uncommon oral lesion that appears as a fiery red, sharply demarcated patch most commonly located on the floor of the mouth, the ventral tongue, or soft palate  (
         <a class="graphic graphic_picture graphicRef87511" href="/z/d/graphic/87511.html" rel="external">
          picture 15
         </a>
         ) [
         <a href="#rid36">
          36,42
         </a>
         ]. It is generally found in older patients who consume tobacco and alcohol and carries a high risk of malignant transformation [
         <a href="#rid43">
          43
         </a>
         ]. In a meta-analysis including 92 studies and nearly 350 patients with oral erythroplakia, the estimated annual rate of malignant transformation for erythroplakia was 2.7 percent [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p>
         On histopathologic examination, erythroplakia frequently shows dysplasia (of variable grade) and carcinoma in situ. Less frequently, it may show features of invasive SCC.
        </p>
        <p>
         Surgical excision with clear margins is a common treatment for oral erythroplakia. In one study of 84 patients with erythroplakia treated with carbon dioxide (CO
         <sub>
          2
         </sub>
         ) laser excision, the recurrence rate was approximately 17 percent [
         <a href="#rid44">
          44
         </a>
         ]. In this study, the lesion size was the main predictor of recurrence, with lesions greater than 80 mm
         <sup>
          2
         </sup>
         having a fivefold increased risk of recurrence compared with smaller lesions. Unfortunately, there are no data available to assess the effectiveness of surgical treatment in reducing oral cancer incidence in patients with erythroplakia. These patients are generally managed similarly to those with leukoplakia. (See
         <a class="medical medical_review" href="/z/d/html/118618.html" rel="external">
          "Oral leukoplakia", section on 'Management'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3803097332">
         <span class="h3">
          Oral submucous fibrosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Oral submucous fibrosis (OSMF) is a chronic, progressive, premalignant condition characterized by submucosal fibrosis involving all of the oral submucosa [
         <a href="#rid23">
          23,45
         </a>
         ]. OSMF occurs only among individuals who chew areca nuts (including betel quid, also known as "paan") and is seen with high frequency in some Southern Asian populations, especially in those from the Indian subcontinent [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p>
         Early symptoms of OSMF include burning sensation of the oral mucosa, ulceration, and pain. This is followed by atrophic changes, pallor, and induration of the mucosa, resulting in a mottled, marble-like appearance  (
         <a class="graphic graphic_picture graphicRef118287" href="/z/d/graphic/118287.html" rel="external">
          picture 16
         </a>
         ) [
         <a href="#rid47">
          47
         </a>
         ]. Fibrosis may extend posteriorly to involve the soft palate and uvula and may also involve the tongue  (
         <a class="graphic graphic_picture graphicRef118288 graphicRef118289" href="/z/d/graphic/118288.html" rel="external">
          picture 17A-B
         </a>
         ). Patients with advanced disease present with restriction of the mouth opening and difficulty with chewing, speaking, and swallowing. Areas of leukoplakia and erythroplakia may also be visible.
        </p>
        <p>
         The diagnosis of OSMF can usually be made based upon the classic clinical features and a history of betel quid chewing. The diagnosis can be confirmed by a mucosal biopsy that shows collagen hyalinization, blood vessel obliteration, and extensive fibrosis extending to the superficial muscle layer [
         <a href="#rid45">
          45
         </a>
         ].
        </p>
        <p>
         Discontinuing consumption of betel products is the mainstay of management, although there is no specific therapy for OSMF. Treatments that have been attempted include intralesional corticosteroids,
         <a class="drug drug_general" data-topicid="16759" href="/z/d/drug information/16759.html" rel="external">
          collagenase
         </a>
         , or
         <a class="drug drug_general" data-topicid="8657" href="/z/d/drug information/8657.html" rel="external">
          hyaluronidase
         </a>
         injections; surgery; or laser therapy. None have proven efficacy.
        </p>
        <p class="headingAnchor" id="H1142698408">
         <span class="h3">
          Oral lichen planus and lichenoid lesions
         </span>
         <span class="headingEndMark">
          —
         </span>
         The presentation of oral lichen planus may vary from lace-like, white patches (Wickham striae  (
         <a class="graphic graphic_picture graphicRef119585 graphicRef76338" href="/z/d/graphic/119585.html" rel="external">
          picture 18A-B
         </a>
         )) on the buccal mucosa to erosions on the gingival margin (desquamative gingivitis), tongue, or buccal mucosa  (
         <a class="graphic graphic_picture graphicRef86888 graphicRef86885 graphicRef54143 graphicRef130117 graphicRef62826 graphicRef130119" href="/z/d/graphic/86888.html" rel="external">
          picture 19A-F
         </a>
         ). (See
         <a class="local">
          'Oral lichen planus'
         </a>
         below.)
        </p>
        <p>
         Oral lichen planus and other lichenoid lesions are also considered potentially malignant conditions, although the magnitude of the associated risk of oral SCC is unclear [
         <a href="#rid48">
          48,49
         </a>
         ]. In a systematic review of 16 observational studies, the rate of transformation ranged from 0 to 3.5 percent [
         <a href="#rid50">
          50
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/15285.html" rel="external">
          "Oral lichen planus: Pathogenesis, clinical features, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/86851.html" rel="external">
          "Oral lichen planus: Management and prognosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1587497622">
         <span class="h3">
          Oral lupus erythematosus
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lesions of oral lupus erythematosus (OLE) include white plaques; silvery white, scarred lesions; and punched-out erosions or ulcers with surrounding erythema  (
         <a class="graphic graphic_picture graphicRef118330" href="/z/d/graphic/118330.html" rel="external">
          picture 20
         </a>
         ) [
         <a href="#rid51">
          51
         </a>
         ]. The oral mucosa is involved in up to 50 percent of patients with OLE and may occasionally be the only manifestation of the disease [
         <a href="#rid45">
          45,48,52-54
         </a>
         ].
        </p>
        <p>
         The diagnosis of OLE requires a biopsy and is based upon the histopathologic finding of hyperkeratosis; focal liquefaction of the basal layer; and presence of a dermal, band-like, lichenoid infiltrate [
         <a href="#rid51">
          51,55
         </a>
         ]. Management of OLE is reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/4666.html" rel="external">
          "Overview of cutaneous lupus erythematosus", section on 'Mucosal manifestations'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3868692758">
         <span class="h4">
          Oral chronic graft-versus-host disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Oral chronic graft-versus-host disease (GVHD) is a complication of allogenic hematopoietic stem cell transplantation (HSCT). It may present with erythema, lichenoid lesions (hyperkeratotic, white lines and lacy-appearing lesions  (
         <a class="graphic graphic_picture graphicRef130120 graphicRef73344" href="/z/d/graphic/130120.html" rel="external">
          picture 21A-B
         </a>
         )), ulcerations, mucosal atrophy, and superficial mucoceles. Patients may also have salivary dysfunction, resulting in hyposalivation and xerostomia, and restricted mouth opening due to sclerosis of perioral tissues. The presence of lichenoid lesions is diagnostic of oral chronic GVHD [
         <a href="#rid56">
          56
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3548.html" rel="external">
          "Clinical manifestations and diagnosis of chronic graft-versus-host disease"
         </a>
         .)
        </p>
        <p>
         In patients with chronic GVHD, the mouth is the second most commonly involved site after the skin [
         <a href="#rid57">
          57,58
         </a>
         ]. Oral chronic GVHD is associated with an increased risk of oral cancer. In a Japanese nationwide study using data from the Transplant Registry Unified Management Program, of over 17,500 recipients of HSCT, the risk of oral SCC was nearly 16-fold higher than in the general population [
         <a href="#rid59">
          59
         </a>
         ]. Continued clinical surveillance and biopsy of mucosal lesions are indicated for early diagnosis of oral SCC, especially in patients with long-standing disease.
        </p>
        <p>
         Management of oral chronic GVHD and oral health following hematopoietic cell transplant is reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/14228.html" rel="external">
          "Long-term care of the adult hematopoietic cell transplantation survivor", section on 'Oral health'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3550.html" rel="external">
          "Treatment of chronic graft-versus-host disease", section on 'Localized/topical treatments'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1775833974">
         <span class="h3">
          Actinic cheilitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Actinic cheilitis, also called solar cheilitis, is a chronic inflammation of the lips (typically affecting the lower lip) due to sun exposure. This is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/119010.html" rel="external">
          "Actinic cheilitis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H560061359">
         <span class="h2">
          White sponge nevus
         </span>
         <span class="headingEndMark">
          —
         </span>
         White sponge nevus (WSN; also called white sponge nevus of Cannon) is a rare, autosomal dominant disorder that presents during childhood with asymptomatic, diffuse, bilateral, white plaques on the buccal mucosa and tongue  (
         <a class="graphic graphic_picture graphicRef86948" href="/z/d/graphic/86948.html" rel="external">
          picture 22
         </a>
         ). Other mucosal surfaces (eg, nasal, vaginal, rectal) can also be involved.
        </p>
        <p>
         WSN is a rare, autosomal dominant genodermatosis caused by mutations in the keratin 4 (
         <em>
          KRT4
         </em>
         ) or keratin 13 (
         <em>
          KRT13
         </em>
         ) genes [
         <a href="#rid60">
          60,61
         </a>
         ]. Histology shows epithelial thickening, parakeratosis, and extensive vacuolization of the suprabasal keratinocytes [
         <a href="#rid61">
          61
         </a>
         ]. There is no known treatment for WSN, although a beneficial effect of topical
         <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">
          tetracycline
         </a>
         has been reported in a few patients [
         <a href="#rid62">
          62,63
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3680987034">
         <span class="h1">
          PIGMENTED LESIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pigmented lesions of the oral mucosa include those that appear typically melanocytic (black or brown) and those that appear other colors (blue or gray). Although we categorize them separately, there is overlap between the groups. Some causes of melanocytic lesions (eg, some types of drug-induced pigmentation and some nevi) may also appear as blue or gray.
        </p>
        <p class="headingAnchor" id="H3442166583">
         <span class="h2">
          Melanocytic lesions
         </span>
        </p>
        <p class="headingAnchor" id="H2105224053">
         <span class="h3">
          Oral melanotic macules
         </span>
         <span class="headingEndMark">
          —
         </span>
         Melanotic macules or lentigines are the most common mucosal pigmented lesions. They appear as darkly pigmented macules on the lips and oral mucosa, especially at the keratinized sites, such as gingiva and palate  (
         <a class="graphic graphic_picture graphicRef112648 graphicRef112649" href="/z/d/graphic/112648.html" rel="external">
          picture 23A-B
         </a>
         ). They are typically symmetric with sharp borders, occur in adulthood, and are more common in individuals with darker complexions [
         <a href="#rid64">
          64
         </a>
         ]. They typically occur as a single lesion, although more than one can sometimes develop.
        </p>
        <p>
         Classically, multiple melanotic macules are found in patients with Laugier-Hunziker syndrome or Peutz-Jeghers syndrome  (
         <a class="graphic graphic_picture graphicRef94244" href="/z/d/graphic/94244.html" rel="external">
          picture 24
         </a>
         ). These and other disorders characterized by hyperpigmented lesions are reviewed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2533.html" rel="external">
          "Peutz-Jeghers syndrome: Clinical manifestations, diagnosis, and management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/89268.html" rel="external">
          "Acquired hyperpigmentation disorders", section on 'Laugier-Hunziker syndrome'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1894763385">
         <span class="h3">
          Drug-induced pigmentation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Drug-induced pigmentation can affect any mucosal site but is more commonly seen on the palate, tongue, and gingivae. Agents most commonly causing oral pigmentation include
         <a class="drug drug_general" data-topicid="9244" href="/z/d/drug information/9244.html" rel="external">
          chlorhexidine
         </a>
         mouthwashes, quinacrine,
         <a class="drug drug_general" data-topicid="9247" href="/z/d/drug information/9247.html" rel="external">
          chloroquine
         </a>
         ,
         <a class="drug drug_general" data-topicid="8541" href="/z/d/drug information/8541.html" rel="external">
          hydroxychloroquine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9846" href="/z/d/drug information/9846.html" rel="external">
          quinidine
         </a>
         ,
         <a class="drug drug_general" data-topicid="10053" href="/z/d/drug information/10053.html" rel="external">
          zidovudine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">
          tetracycline
         </a>
         ,
         <a class="drug drug_general" data-topicid="9653" href="/z/d/drug information/9653.html" rel="external">
          minocycline
         </a>
         ,
         <a class="drug drug_general" data-topicid="107872" href="/z/d/drug information/107872.html" rel="external">
          clofazimine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9252" href="/z/d/drug information/9252.html" rel="external">
          chlorpromazine
         </a>
         , oral contraceptives,
         <a class="drug drug_general" data-topicid="9308" href="/z/d/drug information/9308.html" rel="external">
          cyclophosphamide
         </a>
         ,
         <a class="drug drug_general" data-topicid="9173" href="/z/d/drug information/9173.html" rel="external">
          busulfan
         </a>
         ,
         <a class="drug drug_general" data-topicid="9160" href="/z/d/drug information/9160.html" rel="external">
          bleomycin
         </a>
         , and
         <a class="drug drug_general" data-topicid="8464" href="/z/d/drug information/8464.html" rel="external">
          fluorouracil
         </a>
         [
         <a href="#rid65">
          65,66
         </a>
         ]. Mucosal hyperpigmentation occurs through different mechanisms, including deposition of the agent on oral mucosal surfaces, stimulation of melanin synthesis, drug or metabolite accumulation, and bacterial metabolism.
        </p>
        <p class="headingAnchor" id="H1994678574">
         <span class="h3">
          Smoker's melanosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Smoker's melanosis is characterized by irregular, macular hyperpigmentation of the oral mucosa [
         <a href="#rid67">
          67
         </a>
         ]. Lesions consist of brown patches that are most commonly located on the anterior mandibular gingivae in cigarette smokers and on the buccal mucosa in pipe smokers.
        </p>
        <p>
         The melanosis may be due to the stimulating effect of nicotine on the melanocytes located in the basal layer of the oral mucosa. The intensity of pigmentation is related to the amount and duration of smoking. In those who engage in "reverse smoking" (smoking from the lit end of the cigarette), pigmentation changes are most common on the hard palate (smoker's palate) and are thought to be, in part, caused by repeated thermal injury [
         <a href="#rid68">
          68
         </a>
         ].
        </p>
        <p>
         Smoker's melanosis gradually disappears over months to years after smoking cessation.
        </p>
        <p class="headingAnchor" id="H3429984666">
         <span class="h3">
          Oral melanoacanthoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Oral melanoacanthoma is a rare oral lesion that presents as a rapidly enlarging, asymptomatic, pigmented macule  (
         <a class="graphic graphic_picture graphicRef118582" href="/z/d/graphic/118582.html" rel="external">
          picture 25
         </a>
         ). It predominantly occurs in individuals with highly pigmented skin and is thought to be a reactive response to local trauma or chronic irritation. On histopathologic examination, it is a benign, mixed lesion composed of keratinocytes and dendritic melanocytes [
         <a href="#rid12">
          12,69
         </a>
         ]. Biopsy is required to exclude mucosal melanoma.
        </p>
        <p class="headingAnchor" id="H660507362">
         <span class="h3">
          Melanocytic nevi
         </span>
         <span class="headingEndMark">
          —
         </span>
         Oral melanocytic nevi are uncommon lesions that usually present as a solitary, brown or blue, well-circumscribed nodule or macule  (
         <a class="graphic graphic_picture graphicRef118585" href="/z/d/graphic/118585.html" rel="external">
          picture 26
         </a>
         ) [
         <a href="#rid69">
          69
         </a>
         ]. Biopsy is required since they can resemble mucosal melanoma.
        </p>
        <p class="headingAnchor" id="H2918035722">
         <span class="h3">
          Melanoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Melanoma of the oral mucosa is a rare and highly aggressive, malignant neoplasm of the mouth. It most commonly occurs on the hard palate or maxillary alveolus, although any oral mucosa can be involved. (See
         <a class="medical medical_review" href="/z/d/html/16904.html" rel="external">
          "Locoregional mucosal melanoma: Epidemiology, clinical diagnosis, and treatment", section on 'Mucosal melanoma of the head and neck'
         </a>
         .)
        </p>
        <p>
         Early mucosal melanoma may present as a pigmented macule or patch that may have some of the characteristics of cutaneous melanoma, such as asymmetry, irregular borders, variegate color, and rapid growth  (
         <a class="graphic graphic_picture graphicRef118923" href="/z/d/graphic/118923.html" rel="external">
          picture 27
         </a>
         ). Rarely, oral melanomas can be amelanotic [
         <a href="#rid70">
          70
         </a>
         ]. More advanced lesions can present as raised, nodular or polypoid masses and may be ulcerated or bleeding. Satellite lesions and areas of pre-existing melanosis may be observed around the lesion.
        </p>
        <p>
         Early oral melanoma must be differentiated from other pigmented lesions of the oral mucosa, either melanocytic (eg, melanotic macule, melanocytic nevi, melanoacanthoma) or nonmelanocytic (eg, amalgam tattoos, drug-associated pigmentation). If there is any concern, a biopsy is needed to exclude the diagnosis of melanoma. (See
         <a class="local">
          'Oral melanotic macules'
         </a>
         above and
         <a class="local">
          'Amalgam tattoos'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1319076865">
         <span class="h2">
          Nonmelanocytic pigmentation
         </span>
        </p>
        <p class="headingAnchor" id="H1218936508">
         <span class="h3">
          Amalgam tattoos
         </span>
         <span class="headingEndMark">
          —
         </span>
         Amalgam tattoos are blue-black macules seen within the gingiva at the gingival margin or in the buccal mucosa adjacent to amalgam dental fillings  (
         <a class="graphic graphic_picture graphicRef130121 graphicRef51720" href="/z/d/graphic/130121.html" rel="external">
          picture 28A-B
         </a>
         ). They are caused by the unintentional placement of "silver" dental amalgam in close proximity to or directly into the soft tissues. The most common site for amalgam tattoos is the mandibular arch [
         <a href="#rid71">
          71
         </a>
         ]. Their appearance may mimic oral melanomas; histologic or radiologic visualization of the amalgam particles may be needed to confirm the diagnosis. Similar lesions can be caused by substances other than classic "silver" dental amalgam, such as endodontic materials or graphite.
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h1">
          EROSIVE, ULCERATIVE, AND BULLOUS LESIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Erosive, ulcerative, and bullous oral lesions are very common, with a broad differential diagnosis including infectious, autoimmune, and inflammatory processes. The lesions may appear different depending upon the time of evaluation of the lesion; thus, the clinical history is particularly important to elicit.
        </p>
        <p class="headingAnchor" id="H2515181818">
         <span class="h2">
          Aphthous ulcerations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Aphthous ulcerations (aphthae) are
         <strong>
          painful
         </strong>
         oral lesions that appear as localized, shallow, round to oval ulcers with a yellowish adherent central exudate  (
         <a class="graphic graphic_picture graphicRef114284" href="/z/d/graphic/114284.html" rel="external">
          picture 29C
         </a>
         ). Recurrent aphthous stomatitis (also commonly called canker sores) is the most common cause of mouth ulcers. (See
         <a class="medical medical_review" href="/z/d/html/112654.html" rel="external">
          "Recurrent aphthous stomatitis"
         </a>
         .)
        </p>
        <p>
         Aphthous ulcerations may occur in the absence of underlying systemic disease but may also be seen in patients with celiac disease, inflammatory bowel disease, Behçet syndrome, acute HIV infection, systemic lupus erythematosus (SLE), and neutropenia (of any etiology); individuals with micronutrient deficiencies; and in patients taking antimetabolites, such as
         <a class="drug drug_general" data-topicid="9630" href="/z/d/drug information/9630.html" rel="external">
          methotrexate
         </a>
         . (See
         <a class="medical medical_review" href="/z/d/html/4774.html" rel="external">
          "Epidemiology, pathogenesis, and clinical manifestations of celiac disease in adults", section on 'Mucocutaneous'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4070.html" rel="external">
          "Clinical manifestations, diagnosis, and prognosis of Crohn disease in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8223.html" rel="external">
          "Clinical manifestations and diagnosis of Behçet syndrome"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/86984.html" rel="external">
          "Acute and early HIV infection: Clinical manifestations and diagnosis", section on 'Oropharyngeal findings'
         </a>
         and
         <a class="local">
          'Oral lupus erythematosus'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/4668.html" rel="external">
          "Clinical manifestations and diagnosis of systemic lupus erythematosus in adults", section on 'Clinical manifestations'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7509.html" rel="external">
          "Major side effects of low-dose methotrexate"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H757722">
         <span class="h3">
          Recurrent aphthous stomatitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Recurrent aphthous stomatitis is the most common cause of mouth ulcers [
         <a href="#rid72">
          72
         </a>
         ]. It occurs more commonly in adolescents and young adults and is characterized by the recurrent development of discrete, painful ulcers predominantly located on the nonmasticatory mucosal surfaces  (
         <a class="graphic graphic_picture graphicRef63475" href="/z/d/graphic/63475.html" rel="external">
          picture 29A
         </a>
         and
         <a class="graphic graphic_picture graphicRef114283" href="/z/d/graphic/114283.html" rel="external">
          picture 29B
         </a>
         and
         <a class="graphic graphic_picture graphicRef114284" href="/z/d/graphic/114284.html" rel="external">
          picture 29C
         </a>
         ). Morphologically, ulcers can be minor (&lt;1 cm in diameter), major (&gt;1 cm), or herpetiform (clusters of minute ulcers 1 to 2 mm in diameter that sometimes coalesce into larger ulcers).
        </p>
        <p>
         Patients with recurrent aphthous stomatitis typically experience several recurrences per year, involving one to several ulcers that last up to 14 days. Trauma to the oral mucosa, such as biting the inside of the cheek or undergoing a dental procedure, may be a precipitating factor for many patients.
        </p>
        <p>
         The severe variant of recurrent aphthous stomatitis is characterized by the absence of ulcer-free periods and often associated with chronic pain, malnutrition, and weight loss [
         <a href="#rid73">
          73
         </a>
         ].
        </p>
        <p>
         The diagnosis, clinical presentation, and management of recurrent aphthous stomatitis are discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/112654.html" rel="external">
          "Recurrent aphthous stomatitis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2265335448">
         <span class="h3">
          Oral and genital aphthous ulcerations
         </span>
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h4">
          Behçet syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Behçet syndrome (or Behçet disease) is an inflammatory, multisystemic disorder with vascular, articular, gastrointestinal, neurologic, urogenital, pulmonary, and cardiac involvement:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oral ulcers are the most common feature of Behçet syndrome, affecting up to 100 percent of patients. They are usually the first manifestation of the disease and present clinically and histologically similar to common aphthous ulcers. However, they tend to be more extensive and often multiple  (
         <a class="graphic graphic_picture graphicRef76223" href="/z/d/graphic/76223.html" rel="external">
          picture 30
         </a>
         ). Healing of the oral ulcerations is typically spontaneous within one to three weeks; although with recurrent lesions, many patients will have ulcers present almost constantly.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Genital lesions occur in approximately 75 percent of patients with Behçet syndrome. They are similar in appearance to the oral aphthae.
        </p>
        <p>
        </p>
        <p>
         Recurrent oral ulcers (three times per year) are required for the diagnosis of Behçet syndrome, in addition to two other clinical findings (recurrent genital ulcers, eye lesions, skin lesions, or a positive pathergy test [24 to 48 hours after oblique insertion of a 20 to 25 gauge needle])  (
         <a class="graphic graphic_table graphicRef54762" href="/z/d/graphic/54762.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid74">
          74
         </a>
         ].
        </p>
        <p>
         Further review of the evaluation, diagnosis, and treatment of Behçet syndrome is reviewed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/8223.html" rel="external">
          "Clinical manifestations and diagnosis of Behçet syndrome"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8239.html" rel="external">
          "Treatment of Behçet syndrome"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1209375054">
         <span class="h4">
          Complex aphthosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Complex aphthosis is the term used to describe the occurrence of recurrent, large oral ulcers in conjunction with genital lesions in the absence of other criteria for Behçet syndrome [
         <a href="#rid75">
          75,76
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/112654.html" rel="external">
          "Recurrent aphthous stomatitis", section on 'Clinical subtypes'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4155696847">
         <span class="h4">
          Other
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other syndromes associated with both oral and genital ulcers include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         MAGIC (
         <strong>
          m
         </strong>
         outh
         <strong>
          a
         </strong>
         nd
         <strong>
          g
         </strong>
         enital ulcers with
         <strong>
          i
         </strong>
         nflamed
         <strong>
          c
         </strong>
         artilage) syndrome, which represents an overlap syndrome of relapsing polychondritis and Behçet syndrome [
         <a href="#rid77">
          77
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5606.html" rel="external">
          "Clinical manifestations of relapsing polychondritis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         PFAPA (
         <strong>
          p
         </strong>
         eriodic
         <strong>
          f
         </strong>
         ever,
         <strong>
          a
         </strong>
         phthosis,
         <strong>
          p
         </strong>
         haryngitis, and
         <strong>
          a
         </strong>
         denitis) syndrome is a rare entity of unknown etiology usually affecting children [
         <a href="#rid78">
          78
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5953.html" rel="external">
          "Periodic fever with aphthous stomatitis, pharyngitis, and adenitis (PFAPA syndrome)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cyclic neutropenia is a rare, autosomal dominant disorder of bone marrow progenitor cells characterized by recurrent neutropenia, with a cycle period of approximately 21 days. Clinical features include fever, pharyngitis, gingivitis, oral ulcers, and periodontitis. (See
         <a class="medical medical_review" href="/z/d/html/8370.html" rel="external">
          "Cyclic neutropenia"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oral and vulvar aphthae have also been associated with
         <em>
          Yersinia enterocolitis
         </em>
         infection, tuberculosis, and typhoid fever. (See
         <a class="medical medical_review" href="/z/d/html/3139.html" rel="external">
          "Yersiniosis: Infection due to Yersinia enterocolitica and Yersinia pseudotuberculosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7026.html" rel="external">
          "Pulmonary tuberculosis: Clinical manifestations and complications"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2708.html" rel="external">
          "Enteric (typhoid and paratyphoid) fever: Epidemiology, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4241025576">
         <span class="h2">
          Infectious ulcerations and vesicles
         </span>
        </p>
        <p class="headingAnchor" id="H1743602899">
         <span class="h3">
          Herpes simplex virus
         </span>
         <span class="headingEndMark">
          —
         </span>
         Herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) can infect any mucocutaneous tissue but most commonly involve the tissues of the oral cavity and perioral area. Herpetic gingivostomatitis is the most common clinical manifestation of primary herpes simplex infection in children and young adults  (
         <a class="graphic graphic_picture graphicRef71764" href="/z/d/graphic/71764.html" rel="external">
          picture 31
         </a>
         ) [
         <a href="#rid79">
          79
         </a>
         ]. Usually associated with nonspecific, systemic signs and symptoms (mild fever, malaise, local lymphadenopathy), it is characterized by painful, small ulcers that may coalesce to form larger lesions, affecting the lips and any other oral mucosal site, including the gingivae, palate, or tongue. (See
         <a class="medical medical_review" href="/z/d/html/8334.html" rel="external">
          "Epidemiology, clinical manifestations, and diagnosis of herpes simplex virus type 1 infection", section on 'Primary infection'
         </a>
         .)
        </p>
        <p>
         Recurrent infection is common. Most patients (&gt;85 percent) develop prodromal symptoms (eg, pain, burning, tingling) approximately 24 hours before the appearance of painful lesions at the lip borders or inside the mouth. Precipitating factors include exposure to sunlight, trauma (including dental treatments), menstruation, and emotional stress. Because the primary HSV infection may be asymptomatic, a recurrence may be the first manifestation of infection.
        </p>
        <p>
         Recurrences are more frequent and severe in immunocompromised patients. Chronic mucocutaneous herpes simplex infection, characterized by multiple verrucous, erosive, or ulcerated lesions, can be seen in patients with HIV infection and, occasionally, in patients with other types of immunosuppression [
         <a href="#rid80">
          80
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8334.html" rel="external">
          "Epidemiology, clinical manifestations, and diagnosis of herpes simplex virus type 1 infection", section on 'Recurrent infection'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8334.html" rel="external">
          "Epidemiology, clinical manifestations, and diagnosis of herpes simplex virus type 1 infection", section on 'Immunocompromised hosts'
         </a>
         .)
        </p>
        <p>
         The diagnosis of herpetic infection is generally clinical. Available confirmatory investigations include HSV DNA detection by polymerase chain reaction (PCR), rapid direct immunofluorescence assays (DFAs), serologic tests showing immunoglobulin G (IgG)- and immunoglobulin M (IgM)-specific antibody responses [
         <a href="#rid81">
          81
         </a>
         ], and presence of multinucleated giant cells on a Tzanck smear (these are also seen with varicella-zoster virus infection). (See
         <a class="medical medical_review" href="/z/d/html/5562.html" rel="external">
          "Office-based dermatologic diagnostic procedures", section on 'Tzanck smear'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8334.html" rel="external">
          "Epidemiology, clinical manifestations, and diagnosis of herpes simplex virus type 1 infection", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
         The treatment of primary and recurrent HSV-1 infection is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/8287.html" rel="external">
          "Treatment and prevention of herpes simplex virus type 1 in immunocompetent adolescents and adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2226328132">
         <span class="h3">
          Varicella-zoster virus
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients with primary varicella (chickenpox) infection, oral vesicles and erosions are commonly seen  (
         <a class="graphic graphic_picture graphicRef83137 graphicRef83136" href="/z/d/graphic/83137.html" rel="external">
          picture 32A-B
         </a>
         ).
        </p>
        <p>
         In patients with herpes zoster (shingles), grouped vesicles or erosions may be seen unilaterally in the affected dermatome, such as the hard palate  (
         <a class="graphic graphic_picture graphicRef51866" href="/z/d/graphic/51866.html" rel="external">
          picture 32C
         </a>
         ), the buccal mucosa, tongue, or gingiva. (See
         <a class="medical medical_review" href="/z/d/html/8327.html" rel="external">
          "Epidemiology, clinical manifestations, and diagnosis of herpes zoster"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1971167019">
         <span class="h3">
          Coxsackievirus
         </span>
         <span class="headingEndMark">
          —
         </span>
         Coxsackievirus A causes hand, foot, and mouth disease, an infection that most commonly affects children. Oral lesions typically appear as small aphthae on the tongue and buccal mucosa, often sparing the lips and gingiva (in contrast to HSV). Lesions on the palms and soles appear as oval-shaped, pale papules with a rim of erythema  (
         <a class="graphic graphic_picture graphicRef58566 graphicRef71314 graphicRef81027 graphicRef52800 graphicRef53423" href="/z/d/graphic/58566.html" rel="external">
          picture 33A-E
         </a>
         ). Fever, sore throat, and malaise often precede the onset of lesions. (See
         <a class="medical medical_review" href="/z/d/html/2693.html" rel="external">
          "Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2708672889">
         <span class="h3">
          HIV infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         A variety of oral manifestations are associated with HIV infection, although successful management with contemporary antiretroviral therapies has significantly reduced their incidence [
         <a href="#rid82">
          82-84
         </a>
         ].
        </p>
        <p>
         Painful mucocutaneous ulcerations can be seen in the setting of acute HIV infection. (See
         <a class="medical medical_review" href="/z/d/html/86984.html" rel="external">
          "Acute and early HIV infection: Clinical manifestations and diagnosis", section on 'Oropharyngeal findings'
         </a>
         .)
        </p>
        <p>
         In addition, recurrent aphthous ulcers occur in 0.6 to 13.6 percent of patients with HIV infection, the majority of whom have CD4 cell counts below 100 cells per mm
         <sup>
          3
         </sup>
         [
         <a href="#rid85">
          85
         </a>
         ]. Healing of oral ulcers has been reported with antiretroviral therapy [
         <a href="#rid86">
          86
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3428363674">
         <span class="h3">
          Syphilis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The classic lesion of primary oral syphilis (oral chancre) is a painless ulcer with indurated margins  (
         <a class="graphic graphic_picture graphicRef82771" href="/z/d/graphic/82771.html" rel="external">
          picture 34D
         </a>
         ). In secondary syphilis, oral mucous patches  (
         <a class="graphic graphic_picture graphicRef66008 graphicRef72680 graphicRef52729" href="/z/d/graphic/66008.html" rel="external">
          picture 34A-C
         </a>
         ) can be seen in association with the classic papulosquamous eruption involving the palms and soles and anal condylomata lata. (See
         <a class="medical medical_review" href="/z/d/html/7584.html" rel="external">
          "Syphilis: Epidemiology, pathophysiology, and clinical manifestations in patients without HIV", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3700495552">
         <span class="h3">
          Other infections
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other infections that may also cause oral ulcerations include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Invasive fungal infections, such as oral cryptococcosis, histoplasmosis, mucormycosis (zygomycosis), aspergillosis, and penicilliosis, are uncommon and predominantly occur in immunosuppressed patients [
         <a href="#rid87">
          87-91
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oral ulcerations have been reported secondary to infection with atypical
         <em>
          Mycobacterium
         </em>
         species,
         <em>
          Helicobacter pylori
         </em>
         , and
         <em>
          Leishmania
         </em>
         [
         <a href="#rid92">
          92
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16.html" rel="external">
          "Bacteriology and epidemiology of Helicobacter pylori infection"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5689.html" rel="external">
          "Cutaneous leishmaniasis: Clinical manifestations and diagnosis", section on 'Mucosal leishmaniasis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H24">
         <span class="h2">
          Immune-mediated ulcerations and bullae
         </span>
        </p>
        <p class="headingAnchor" id="H925537378">
         <span class="h3">
          Oral lichen planus
         </span>
         <span class="headingEndMark">
          —
         </span>
         The erosive clinical subtype of oral lichen planus is characterized by erosions or frank ulcers  (
         <a class="graphic graphic_picture graphicRef130122 graphicRef62826 graphicRef54143" href="/z/d/graphic/130122.html" rel="external">
          picture 19C, 19E, 19G
         </a>
         ). Reticular and erythematous lesions are also usually present. (See
         <a class="medical medical_review" href="/z/d/html/15285.html" rel="external">
          "Oral lichen planus: Pathogenesis, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H25">
         <span class="h3">
          Oral lupus erythematosus
         </span>
         <span class="headingEndMark">
          —
         </span>
         Up to 50 percent of patients with systemic lupus erythematosus (SLE) have mucous membrane involvement [
         <a href="#rid52">
          52-54
         </a>
         ]. Oral disease can involve the lips or other oral mucosa and may manifest as white plaques, areas of erythema, or punched-out erosions or ulcers with surrounding erythema on the soft or hard palate or buccal mucosa  (
         <a class="graphic graphic_picture graphicRef130123 graphicRef63605" href="/z/d/graphic/130123.html" rel="external">
          picture 35A-B
         </a>
         ). The oral ulcers are typically painless and may be the first sign of SLE. (See
         <a class="medical medical_review" href="/z/d/html/4668.html" rel="external">
          "Clinical manifestations and diagnosis of systemic lupus erythematosus in adults", section on 'Mucocutaneous involvement'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H27">
         <span class="h3">
          Mucous membrane pemphigoid
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mucous membrane pemphigoid (MMP) is an autoimmune bullous disease characterized by subepithelial blisters affecting any mucous membrane, although oral mucous membranes are most commonly involved. Desquamative gingivitis (desquamation, erythema, and erosion of gingiva) is a prominent feature  (
         <a class="graphic graphic_picture graphicRef130124 graphicRef77654" href="/z/d/graphic/130124.html" rel="external">
          picture 36A-B
         </a>
         ), but erosive and ulcerative lesions can also be found on the palate  (
         <a class="graphic graphic_picture graphicRef63997" href="/z/d/graphic/63997.html" rel="external">
          picture 36C
         </a>
         ) [
         <a href="#rid93">
          93,94
         </a>
         ]. In some patients, there is cutaneous involvement as well. Typical patients are females in their sixties, although men can be affected as well.
        </p>
        <p>
         The diagnosis is made on routine histopathology and direct immunofluorescence testing of perilesional mucosa, along with the appropriate clinical findings. Further discussion of the evaluation, diagnosis, and treatment of MMP can be found elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/16176.html" rel="external">
          "Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid", section on 'Clinical features of mucous membrane pemphigoid'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/83575.html" rel="external">
          "Management of mucous membrane pemphigoid"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2106912993">
         <span class="h3">
          Bullous pemphigoid
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bullous pemphigoid is another autoimmune blistering disorder. Cutaneous lesions (bullae or urticarial plaques) commonly occur in the flexural areas, groin, and axillae. Oral involvement, characterized by intact bullae or erosions, occurs in approximately one-third of cases but is rarely the presenting feature.
        </p>
        <p>
         The diagnosis is made on routine histopathology and direct immunofluorescence testing of lesional and perilesional skin, respectively. Further discussion of the diagnosis and management of bullous pemphigoid can be found elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/16176.html" rel="external">
          "Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid", section on 'Clinical features of bullous pemphigoid'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15297.html" rel="external">
          "Management and prognosis of bullous pemphigoid"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H28">
         <span class="h3">
          Pemphigus vulgaris
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pemphigus vulgaris is characterized by flaccid, intraepithelial bullae that typically begin in the oral cavity and then may progress to involve the skin, with a predilection for the scalp, face, chest, axillae, and groin  (
         <a class="graphic graphic_picture graphicRef57924" href="/z/d/graphic/57924.html" rel="external">
          picture 37
         </a>
         ). The bullae rupture easily, so that the patient often presents with only painful erosions and ulcers but no intact bullae.
        </p>
        <p>
         The pathogenesis, clinical manifestations, diagnosis, and treatment of pemphigus vulgaris are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/83684.html" rel="external">
          "Pathogenesis, clinical manifestations, and diagnosis of pemphigus"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15303.html" rel="external">
          "Initial management of pemphigus vulgaris and pemphigus foliaceus"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15304.html" rel="external">
          "Management of refractory pemphigus vulgaris and pemphigus foliaceus"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5099311">
         <span class="h3">
          Paraneoplastic pemphigus
         </span>
         <span class="headingEndMark">
          —
         </span>
         Paraneoplastic pemphigus is a mucocutaneous blistering disorder most often associated with lymphoproliferative disorders [
         <a href="#rid95">
          95,96
         </a>
         ]. Severe, erosive, painful mucositis is the hallmark clinical finding in paraneoplastic pemphigus. In its absence, the diagnosis should not be considered. The painful, erosive stomatitis can involve any oral mucosa but characteristically involves the tongue  (
         <a class="graphic graphic_picture graphicRef59594 graphicRef79518 graphicRef54382" href="/z/d/graphic/59594.html" rel="external">
          picture 38A-C
         </a>
         ). While cutaneous and pulmonary manifestations can also be present, oral erosions are the initial disease manifestation in almost one-half of patients [
         <a href="#rid97">
          97
         </a>
         ].
        </p>
        <p>
         The clinical manifestations, diagnosis, and treatment of paraneoplastic pemphigus are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/15305.html" rel="external">
          "Paraneoplastic pemphigus"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2324698690">
         <span class="h3">
          Epidermolysis bullosa acquisita
         </span>
         <span class="headingEndMark">
          —
         </span>
         Epidermolysis bullosa acquisita is a rare, autoimmune mucocutaneous bullous disease that presents with blisters localized predominantly at sites of trauma, which heal with scarring and milia. Erosions and blisters may involve any mucous membrane, including the mouth. Epidermolysis bullosa acquisita is discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/15299.html" rel="external">
          "Epidermolysis bullosa acquisita"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2912498668">
         <span class="h3">
          Erythema multiforme
         </span>
         <span class="headingEndMark">
          —
         </span>
         Erythema multiforme is an immune-mediated condition characterized by the acute appearance of distinctive, cutaneous, target-like lesions often accompanied by erosions or bullae involving the oral, genital, and/or ocular mucous membranes. Oral involvement is common, occurring in over 70 percent of patients  (
         <a class="graphic graphic_picture graphicRef68153 graphicRef62370" href="/z/d/graphic/68153.html" rel="external">
          picture 39A-B
         </a>
         and
         <a class="graphic graphic_picture graphicRef58969" href="/z/d/graphic/58969.html" rel="external">
          picture 39C
         </a>
         ) [
         <a href="#rid98">
          98
         </a>
         ]. In the majority of cases, erythema multiforme is associated with herpes simplex infection, but it also may be associated with other infections (eg,
         <em>
          Mycoplasma pneumoniae
         </em>
         ) or drugs or may be idiopathic. The etiology, clinical presentation, evaluation, and management of erythema multiforme is reviewed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/5559.html" rel="external">
          "Erythema multiforme: Pathogenesis, clinical features, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5561.html" rel="external">
          "Erythema multiforme: Management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H353301534">
         <span class="h2">
          Non-immune-mediated ulcerations and bullae
         </span>
        </p>
        <p class="headingAnchor" id="H812448872">
         <span class="h3">
          Inherited epidermolysis bullosa
         </span>
         <span class="headingEndMark">
          —
         </span>
         Epidermolysis bullosa is a group of genetically and clinically heterogeneous, inherited skin fragility disorders with the common finding of epithelial fragility. The most commonly affected sites include areas of trauma and friction. Milder forms do not typically involve the mucosae, while more severe manifestations involve the oral, pharyngeal, and esophageal mucosa. (See
         <a class="medical medical_review" href="/z/d/html/15449.html" rel="external">
          "Epidermolysis bullosa: Epidemiology, pathogenesis, classification, and clinical features"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1885980196">
         <span class="h2">
          Drug-induced ulcerations
         </span>
        </p>
        <p class="headingAnchor" id="H215243421">
         <span class="h3">
          Stevens-Johnson syndrome/toxic epidermal necrolysis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a severe mucocutaneous reaction characterized by extensive necrosis and detachment of the epidermis that is most commonly caused by medications. In over 90 percent of patients with SJS/TEN, there is mucosal involvement, which can precede or follow the skin eruption. Lesions of the involved oral mucosa typically appear as painful, hemorrhagic erosions covered with a grayish-white membrane  (
         <a class="graphic graphic_picture graphicRef68682" href="/z/d/graphic/68682.html" rel="external">
          picture 40A
         </a>
         and
         <a class="graphic graphic_picture graphicRef73805" href="/z/d/graphic/73805.html" rel="external">
          picture 40B
         </a>
         ).
        </p>
        <p>
         The clinical manifestations, diagnosis, and treatment of SJS/TEN are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/2091.html" rel="external">
          "Stevens-Johnson syndrome and toxic epidermal necrolysis: Pathogenesis, clinical manifestations, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2092.html" rel="external">
          "Stevens-Johnson syndrome and toxic epidermal necrolysis: Management, prognosis, and long-term sequelae"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2236655097">
         <span class="h3">
          mTOR inhibitor-associated stomatitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mammalian (mechanistic) target of rapamycin (mTOR) inhibitor-associated stomatitis (mIAS) is a common adverse event, occurring in approximately 30 percent of patients taking
         <a class="drug drug_general" data-topicid="9078" href="/z/d/drug information/9078.html" rel="external">
          everolimus
         </a>
         and
         <a class="drug drug_general" data-topicid="10344" href="/z/d/drug information/10344.html" rel="external">
          temsirolimus
         </a>
         for the treatment of several types of cancer [
         <a href="#rid99">
          99
         </a>
         ]. mIAS is characterized by discrete, superficial, oval, well-demarcated ulcers with a grayish-white pseudomembrane, usually ≤1 cm in greatest dimension, located on the oral mucosa and tongue. Painful oral ulcerations have also been reported in allogeneic hematopoietic stem cell transplantation recipients treated with
         <a class="drug drug_general" data-topicid="10329" href="/z/d/drug information/10329.html" rel="external">
          sirolimus
         </a>
         for the prevention of graft-versus-host disease [
         <a href="#rid100">
          100-102
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1152.html" rel="external">
          "Oral toxicity associated with systemic anticancer therapy", section on 'Mucositis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2017954980">
         <span class="h3">
          Checkpoint inhibitor-associated oral lesions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Oral mucositis, lichenoid lesions, erythema multiforme-like lesions, erosions, and ulcerations have been reported in patients receiving immune checkpoint inhibitor therapy [
         <a href="#rid103">
          103,104
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16346.html" rel="external">
          "Oral health in cancer survivors"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H278381904">
         <span class="h3">
          Nicorandil-induced ulceration
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nicorandil is a potassium channel activator used in the treatment of angina pectoris and is available only outside of the United States. Its use has been associated with the development of painful skin and mucosal ulcerations in 0.4 to 5 percent of patients [
         <a href="#rid105">
          105-108
         </a>
         ]. The mechanism by which nicorandil induces ulcerations is unknown. Oral ulcers can occur weeks to months after starting treatment, the effect is not dose related, and lesions resolve within a few weeks after withdrawal of the drug [
         <a href="#rid106">
          106,109,110
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H265968309">
         <span class="h1">
          TONGUE LESIONS
         </span>
        </p>
        <p class="headingAnchor" id="H3698485504">
         <span class="h2">
          Normal tongue variants
         </span>
         <span class="headingEndMark">
          —
         </span>
         Tongue appearance may vary, with many normal variants of tongue structure and mucosa commonly seen. The clinical history of any change in appearance or associated sensory changes (eg, pain, burning, loss of taste) is important to elicit.
        </p>
        <p class="headingAnchor" id="H2043472575">
         <span class="h3">
          Fissured tongue
         </span>
         <span class="headingEndMark">
          —
         </span>
         Fissured tongue (also called lingua plicata or scrotal tongue) can be a normal tongue variant seen in adults, with deep grooves located on the midline or evenly distributed on the tongue surface  (
         <a class="graphic graphic_picture graphicRef130125 graphicRef85871" href="/z/d/graphic/130125.html" rel="external">
          picture 41A-B
         </a>
         ). Fissured tongue may also be seen in patients with Down syndrome or Melkersson-Rosenthal syndrome (a rare syndrome characterized by the triad of fissured tongue, facial palsy, and granulomatous cheilitis) [
         <a href="#rid111">
          111,112
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2917.html" rel="external">
          "Down syndrome: Clinical features and diagnosis", section on 'Skin disorders'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5281.html" rel="external">
          "Bell's palsy: Pathogenesis, clinical features, and diagnosis in adults", section on 'Melkersson-Rosenthal syndrome'
         </a>
         .)
        </p>
        <p>
         Patients with fissured tongue are generally asymptomatic, although if irritation from entrapped debris occurs, brushing the tongue or using an oral irrigator may be helpful. Fissured tongue may also be a predisposing factor for halitosis. (See
         <a class="medical medical_review" href="/z/d/html/6843.html" rel="external">
          "Bad breath"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H697274441">
         <span class="h3">
          Black tongue
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hyperpigmentation of the tongue and oral mucosa is commonly seen in dark-skinned individuals.
        </p>
        <p>
         Less common causes of tongue hyperpigmentation include drugs (eg, tetracyclines,
         <a class="drug drug_general" data-topicid="10283" href="/z/d/drug information/10283.html" rel="external">
          linezolid
         </a>
         ,
         <a class="drug drug_general" data-topicid="101044" href="/z/d/drug information/101044.html" rel="external">
          bismuth subsalicylate
         </a>
         , tricyclic antidepressants, proton pump inhibitors, interferon), Addison disease (primary adrenal insufficiency  (
         <a class="graphic graphic_picture graphicRef67179" href="/z/d/graphic/67179.html" rel="external">
          picture 42
         </a>
         )), Laugier-Hunziker disease, or pellagra (niacin deficiency) [
         <a href="#rid113">
          113-117
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/159.html" rel="external">
          "Clinical manifestations of adrenal insufficiency in adults", section on 'Hyperpigmentation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5360.html" rel="external">
          "Micronutrient deficiencies associated with protein-energy malnutrition in children", section on 'Niacin'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/89268.html" rel="external">
          "Acquired hyperpigmentation disorders", section on 'Laugier-Hunziker syndrome'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H206920270">
         <span class="h3">
          Pigmented fungiform papillae
         </span>
         <span class="headingEndMark">
          —
         </span>
         Fungiform papillae are scattered on the dorsal tongue surface, predominantly on the anterior and lateral aspects, and are usually pink or red in color. Individuals with darker skin tones may have pigmented spots on the dorsal tongue due to melanin deposition on the tips of the fungiform papillae  (
         <a class="graphic graphic_picture graphicRef93385" href="/z/d/graphic/93385.html" rel="external">
          picture 43
         </a>
         ) [
         <a href="#rid118">
          118
         </a>
         ]. These spots usually appear during the second or third decade of life and are typically asymptomatic [
         <a href="#rid119">
          119-121
         </a>
         ]. Histologic examination reveals submucosal melanophages within the fungiform papillae in the absence of inflammation.
        </p>
        <p class="headingAnchor" id="H4219829437">
         <span class="h2">
          Atrophic glossitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Atrophic glossitis is a condition characterized by atrophy of the filiform papillae of the tongue, giving the tongue a smooth, glossy, and erythematous appearance  (
         <a class="graphic graphic_picture graphicRef85872 graphicRef54472" href="/z/d/graphic/85872.html" rel="external">
          picture 44A-B
         </a>
         ). Causes of atrophic glossitis include [
         <a href="#rid122">
          122-124
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nutritional deficiencies (iron,
         <a class="drug drug_general" data-topicid="9302" href="/z/d/drug information/9302.html" rel="external">
          vitamin B12
         </a>
         , folate) (see
         <a class="medical medical_review" href="/z/d/html/7150.html" rel="external">
          "Causes and diagnosis of iron deficiency and iron deficiency anemia in adults", section on 'Findings on examination'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7155.html" rel="external">
          "Clinical manifestations and diagnosis of vitamin B12 and folate deficiency"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oral
         <em>
          Candida
         </em>
         infection (see
         <a class="local">
          'Oral candidiasis'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Protein-calorie malnutrition in older adults (see
         <a class="medical medical_review" href="/z/d/html/3016.html" rel="external">
          "Geriatric nutrition: Nutritional issues in older adults"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Celiac disease (see
         <a class="medical medical_review" href="/z/d/html/4771.html" rel="external">
          "Diagnosis of celiac disease in adults"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lichen planus (see
         <a class="medical medical_review" href="/z/d/html/15285.html" rel="external">
          "Oral lichen planus: Pathogenesis, clinical features, and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p>
         Patients with atrophic glossitis often complain of a burning sensation and increased sensitivity when eating acidic or salty foods. Management is directed at treating the underlying condition.
        </p>
        <p class="headingAnchor" id="H2545086566">
         <span class="h2">
          Black hairy tongue
         </span>
         <span class="headingEndMark">
          —
         </span>
         Black hairy tongue (lingua villosa nigra) is characterized by the elongated filiform papillae (due to a lack of adequate desquamation) and a yellowish to brown discoloration of the tongue surface (due to local and extrinsic factors)  (
         <a class="graphic graphic_picture graphicRef76664" href="/z/d/graphic/76664.html" rel="external">
          picture 45
         </a>
         ). This benign condition is associated with smoking, antibiotic use, dehydration,
         <em>
          Candida albicans
         </em>
         infection, and poor oral hygiene. It is often seen in hospitalized patients who are on a gastrostomy tube (G-tube). The condition is generally asymptomatic. Therapy consists of brushing or scraping that area of the tongue with a soft-bristle toothbrush or a specific tool (tongue cleaner) two to three times per day [
         <a href="#rid125">
          125,126
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1255785134">
         <span class="h2">
          Geographic tongue
         </span>
         <span class="headingEndMark">
          —
         </span>
         Geographic tongue (benign migratory glossitis) is a recurrent inflammatory disorder of unknown etiology that affects the dorsum of the tongue and, less frequently, other oral mucosae (benign migratory stomatitis) [
         <a href="#rid127">
          127
         </a>
         ]. On the tongue, local loss of filiform papillae leads to depapillated, red patches with circumferential, white, polycyclic borders that give the dorsal tongue the appearance of a map  (
         <a class="graphic graphic_picture graphicRef74654 graphicRef79512" href="/z/d/graphic/74654.html" rel="external">
          picture 46A-B
         </a>
         ). Lesions can change location, pattern, and size very rapidly (migratory), and patients may have numerous exacerbations and remissions over time. Patients are usually asymptomatic, have only mild symptoms, or complain of oral discomfort, burning, and sensitivity to some foods.
        </p>
        <p>
         The condition has been frequently described in atopic individuals and in association with psoriasis and reactive arthritis. (See
         <a class="medical medical_review" href="/z/d/html/7794.html" rel="external">
          "Reactive arthritis"
         </a>
         .)
        </p>
        <p>
         The differential diagnosis includes oral candidiasis, lichen planus, systemic lupus erythematosus, herpes simplex virus, and drug reaction [
         <a href="#rid127">
          127
         </a>
         ]. The diagnosis is typically based on the clinical presentation, and biopsy is not necessary. However, biopsy may be reassuring in unclear cases. The histology of involved areas is similar to pustular psoriasis.
        </p>
        <p>
         No therapy is needed, although for patients with more bothersome symptoms, symptomatic therapy may be tried. Treatments with unproven benefit include systemic
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         , antihistamines, or anxiolytics; anesthetic mouth rinses; and topical treatments, including
         <a class="drug drug_general" data-topicid="9971" href="/z/d/drug information/9971.html" rel="external">
          tacrolimus
         </a>
         and corticosteroids [
         <a href="#rid128">
          128-130
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3987571838">
         <span class="h2">
          Median rhomboid glossitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Median rhomboid glossitis, also called central papillary atrophy of the tongue, is an uncommon, benign condition presenting as a red, depapillated, somewhat rhomboidal midline lesion on the dorsum of the tongue  (
         <a class="graphic graphic_picture graphicRef118589 graphicRef118243 graphicRef118244" href="/z/d/graphic/118589.html" rel="external">
          picture 9A-C
         </a>
         ). Some patients may have a "kissing" lesion on the hard palate. In the majority of cases, it is a manifestation of oral candidiasis, although idiopathic cases have also been reported [
         <a href="#rid131">
          131,132
         </a>
         ]. Median rhomboid glossitis predominantly affects older adults. Treatment for asymptomatic lesions is not required, although if bothersome, treatment for oral candidiasis is appropriate. (See
         <a class="medical medical_review" href="/z/d/html/2432.html" rel="external">
          "Oropharyngeal candidiasis in adults", section on 'Treatment'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2986960306">
         <span class="h2">
          Granular cell tumor
         </span>
         <span class="headingEndMark">
          —
         </span>
         A granular cell tumor is a benign neoplasm of neural origin composed of cells with granular cytoplasm. Most often, they present as solitary nodules affecting the dorsum of the tongue  (
         <a class="graphic graphic_picture graphicRef100363" href="/z/d/graphic/100363.html" rel="external">
          picture 47
         </a>
         ) but may also occur in the skin, breasts, and gastrointestinal tract [
         <a href="#rid133">
          133
         </a>
         ]. Histologically, granular cell tumors are characterized by sheets or cords of large, polygonal cells with small, round, central nuclei and an eosinophilic, coarse, granular cytoplasm  (
         <a class="graphic graphic_picture graphicRef100364" href="/z/d/graphic/100364.html" rel="external">
          picture 48
         </a>
         ). Occasionally, larger, eosinophilic granules surrounded by a clear halo called pustulo-ovoid bodies of Milian can be seen. Treatment is surgical excision [
         <a href="#rid134">
          134
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2253.html" rel="external">
          "Benign lesions of the esophagus", section on 'Granular cell tumors'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H30">
         <span class="h1">
          MISCELLANEOUS ORAL LESIONS
         </span>
        </p>
        <p class="headingAnchor" id="H932018945">
         <span class="h2">
          Cheilitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cheilitis is an acute or chronic inflammation of the lips characterized by dryness, scaling, erythema, and fissuring. Eczematous cheilitis (including irritant contact cheilitis  (
         <a class="graphic graphic_picture graphicRef54887" href="/z/d/graphic/54887.html" rel="external">
          picture 49
         </a>
         ), allergic contact cheilitis, and atopic cheilitis) is the most common lip condition. Angular cheilitis, also known as perlèche, is another common inflammation affecting the skin and contiguous labial mucosa located at the lateral commissures of the mouth  (
         <a class="graphic graphic_picture graphicRef71723" href="/z/d/graphic/71723.html" rel="external">
          picture 10E
         </a>
         ).
        </p>
        <p>
         The clinical manifestations, diagnosis, and treatment of acute and chronic forms of cheilitis are reviewed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/13654.html" rel="external">
          "Cheilitis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H169989251">
         <span class="h2">
          Mucoceles
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mucoceles are extremely common, benign, cystic lesions found in the mouth, occurring most frequently in the lower lip mucosa of children or young adults (probably as a result of self-biting) [
         <a href="#rid135">
          135
         </a>
         ]. They are rarely found in the upper lip [
         <a href="#rid136">
          136
         </a>
         ]. They are variable in size, contain a gelatinous fluid, and typically appear as pink/blue, soft papules or nodules  (
         <a class="graphic graphic_picture graphicRef70332 graphicRef75671" href="/z/d/graphic/70332.html" rel="external">
          picture 50A-B
         </a>
         and
         <a class="graphic graphic_picture graphicRef142734" href="/z/d/graphic/142734.html" rel="external">
          picture 51
         </a>
         ). The variant that occurs in the floor of the mouth (originating from the duct of the sublingual or submandibular gland) is called "ranula."
        </p>
        <p>
         Mucoceles are lesions of the minor salivary glands or ducts and are epithelium-lined cavities filled with mucus and covered by granulation tissue. They result from damage to a salivary gland or duct with extravasation of mucus into the surrounding tissue. The size of the lesion can vary over time, often as a result of a rupture of the lesion due to lip biting. Occasionally, spontaneous rupture of the mucocele can result in resolution [
         <a href="#rid136">
          136
         </a>
         ], although recurrence is common if the damaged gland is not surgically removed [
         <a href="#rid137">
          137
         </a>
         ].
        </p>
        <p>
         Diagnosis of mucocele is primarily based upon the clinical presentation (eg, classic appearance and texture of the lesion). Aspiration alone may initially relieve symptoms but is rarely indicated except to aid in diagnosis or for short-term relief of irritation, as recurrence is common. Mucoceles are the most commonly biopsied oral lesions in children [
         <a href="#rid138">
          138
         </a>
         ].
        </p>
        <p>
         In all patients, particularly children and their parents/caregivers, reassurance as to the benign nature of the condition is an important element of management. Advising the patient to avoid biting or chewing the lesion is essential; minimizing trauma may promote resolution. The application of warm compresses can reduce inflammation when present. If the lesion recurs, does not resolve spontaneously, or becomes bothersome or concerning to the patient, surgical removal of the entire lesion and histologic confirmation of the diagnosis is the standard management [
         <a href="#rid139">
          139
         </a>
         ]. Carbon dioxide (CO
         <sub>
          2
         </sub>
         ) laser vaporization has also shown good results with a low rate of recurrence and is an option for clinicians experienced with this modality [
         <a href="#rid140">
          140
         </a>
         ]. Intralesional corticosteroid injections have also been used with success [
         <a href="#rid141">
          141
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4003757630">
         <span class="h2">
          Torus palatinus
         </span>
         <span class="headingEndMark">
          —
         </span>
         Torus palatinus, a bony overgrowth (exostosis) located on the midline of the hard palate, appears as a bony, hard, nodular, lobular, or spindle-shaped mass covered with normal mucosa  (
         <a class="graphic graphic_picture graphicRef94936" href="/z/d/graphic/94936.html" rel="external">
          picture 52
         </a>
         ) [
         <a href="#rid142">
          142-144
         </a>
         ].
        </p>
        <p>
         It generally develops during childhood and enlarges slowly over many years. Torus palatinus is generally asymptomatic and is typically an incidental finding during routine physical examination. However, if the mass is rapidly growing (over weeks or months), is not located on the midline, or has an atypical appearance, referral for imaging or biopsy may be warranted.
        </p>
        <p>
         Torus palatinus is very common, with a prevalence of approximately 12 to 27 percent in the general population [
         <a href="#rid145">
          145-147
         </a>
         ].
        </p>
        <p>
         Surgical removal may be an option if patients develop symptoms or the lesion precludes the proper fitting of dentures or other oral prosthetic devices.
        </p>
        <p>
         Torus mandibularis (mandibular exostoses) are similar lesions and probably more common than torus palatinus. They are typically found on the lingual aspect of the mandible [
         <a href="#rid148">
          148
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3666263656">
         <span class="h2">
          Minor salivary gland tumors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Tumors may develop in any of the minor salivary glands. There are approximately 1000 minor glands, each measuring from 1 to 2 mm in size, and are dispersed throughout the oral submucosa. Minor salivary gland tumors may present as a painless, submucosal mass or a mucosal ulceration in the palate, lips, or buccal mucosa. This is reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/3400.html" rel="external">
          "Salivary gland tumors: Epidemiology, diagnosis, evaluation, and staging", section on 'Clinical presentation'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H886683203">
         <span class="h2">
          Gingival overgrowth
         </span>
         <span class="headingEndMark">
          —
         </span>
         Gingival overgrowth may develop as a result of inflammation in response to long-standing gingivitis, particularly in children, or due to certain medications. (See
         <a class="medical medical_review" href="/z/d/html/6282.html" rel="external">
          "Soft tissue lesions of the oral cavity in children", section on 'Gingival overgrowth'
         </a>
         .)
        </p>
        <p>
         Medications associated with enlargement of gingival tissues include
         <a class="drug drug_general" data-topicid="9769" href="/z/d/drug information/9769.html" rel="external">
          phenytoin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9217" href="/z/d/drug information/9217.html" rel="external">
          cyclosporine
         </a>
         , and calcium channel blockers (most commonly
         <a class="drug drug_general" data-topicid="9700" href="/z/d/drug information/9700.html" rel="external">
          nifedipine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9365" href="/z/d/drug information/9365.html" rel="external">
          diltiazem
         </a>
         ,
         <a class="drug drug_general" data-topicid="10043" href="/z/d/drug information/10043.html" rel="external">
          verapamil
         </a>
         , and
         <a class="drug drug_general" data-topicid="8627" href="/z/d/drug information/8627.html" rel="external">
          amlodipine
         </a>
         , although in case reports,
         <a class="drug drug_general" data-topicid="8438" href="/z/d/drug information/8438.html" rel="external">
          felodipine
         </a>
         , nitrendipine, and
         <a class="drug drug_general" data-topicid="9697" href="/z/d/drug information/9697.html" rel="external">
          nicardipine
         </a>
         have also been implicated)  (
         <a class="graphic graphic_picture graphicRef82641" href="/z/d/graphic/82641.html" rel="external">
          picture 53
         </a>
         ) [
         <a href="#rid149">
          149,150
         </a>
         ]. Management of drug-induced gingival overgrowth is reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/6858.html" rel="external">
          "Overview of gingivitis and periodontitis in adults", section on 'Non-plaque-associated gingivitis and gingival disease'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H138773388">
         <span class="h2">
          Oral fibroma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Oral fibromas are common, benign soft tissue growths of the oral mucosa that present as smooth, pink or whitish papules or nodules, sessile or pedunculated, on the oral mucosa  (
         <a class="graphic graphic_picture graphicRef129835 graphicRef129836" href="/z/d/graphic/129835.html" rel="external">
          picture 54A-B
         </a>
         ) [
         <a href="#rid151">
          151
         </a>
         ]. They are usually induced by trauma, and thus, they are typically located at sites that are subject to repeated biting or friction from dentures.
        </p>
        <p class="headingAnchor" id="H72957244">
         <span class="h2">
          Telangiectasias secondary to hereditary hemorrhagic telangiectasia
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients with hereditary hemorrhagic telangiectasia, mucosal telangiectasias can occur anywhere along the gastrointestinal tract and are frequently visible on the lips, tongue, and oral mucosa  (
         <a class="graphic graphic_picture graphicRef96711 graphicRef96712" href="/z/d/graphic/96711.html" rel="external">
          picture 55A-B
         </a>
         ) [
         <a href="#rid152">
          152,153
         </a>
         ].
        </p>
        <p>
         Lesions generally develop by the age 30 years and increase in number over time. Bleeding can occur but rarely requires medical intervention. (See
         <a class="medical medical_review" href="/z/d/html/1345.html" rel="external">
          "Clinical manifestations and diagnosis of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1367253084">
         <span class="h2">
          Contact stomatitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Contact stomatitis (contact mucositis involving the oral or perioral tissues) may present with a variety of lesions (eg, erythematous lesions, vesicles, ulcerations, hyperkeratosis) and discomfort (eg, pain, burning, itchiness)  (
         <a class="graphic graphic_picture graphicRef58869" href="/z/d/graphic/58869.html" rel="external">
          picture 56
         </a>
         ). Irritant contact stomatitis can be induced by mechanical irritation (ie, ill-ﬁtting dentures or irregular dental fillings), physical trauma, or chemical irritation [
         <a href="#rid154">
          154
         </a>
         ]. Chemical irritants include foods, flavorings, oral hygiene products, dental restoration products, tobacco, and drugs (eg,
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         ). Nicotine stomatitis has been described in e-cigarette users [
         <a href="#rid155">
          155
         </a>
         ].
        </p>
        <p>
         Hyperkeratotic lesions resembling leukoplakia can occur due to repeated friction from poorly fitting prostheses, cheek sucking, or with the use of oral tobacco. (See
         <a class="local">
          'Morsicatio buccarum and frictional keratosis'
         </a>
         above.)
        </p>
        <p>
         Allergic contact reactions may occur in response to metallic mercury, cinnamon aldehyde, and gold salts, among others agents  (
         <a class="graphic graphic_table graphicRef54139" href="/z/d/graphic/54139.html" rel="external">
          table 2
         </a>
         ). Lip and perioral involvement is seen when the offending agent is eaten (eg, mango off the skin) or applied topically. Food-related reactions may also present with prominent lip swelling. Lichenoid, lace-like, localized buccal mucosal patches may occur secondary to amalgam allergy.
        </p>
        <p>
         Allergic contact urticaria may be caused by dental materials or natural rubber latex. It presents with rapid development of edema of the lips, tongue, and oral mucosa; anaphylaxis can also occur. Of note, some individuals who are allergic to natural rubber latex may have an associated hypersensitivity to some plant-derived foods, such as avocado, banana, kiwi, chestnut, peach, tomato, white potato, and bell pepper (latex-fruit syndrome). (See
         <a class="medical medical_review" href="/z/d/html/5543.html" rel="external">
          "Latex allergy: Epidemiology, clinical manifestations, and diagnosis", section on 'Allergic contact urticaria'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2402.html" rel="external">
          "Clinical manifestations and diagnosis of oral allergy syndrome (pollen-food allergy syndrome)", section on 'Latex-fruit syndrome'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H23373771">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/16834.html" rel="external">
          "Patient education: Mouth sores (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/83680.html" rel="external">
          "Patient education: Leukoplakia (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3012167382">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Initial evaluation
         </strong>
         – In patients presenting with an oral lesion, we perform a careful intraoral and extraoral tactile and visual examination  (
         <a class="graphic graphic_figure graphicRef69766 graphicRef54845 graphicRef129154" href="/z/d/graphic/69766.html" rel="external">
          figure 1A-C
         </a>
         ). Although the clinician's examination of the oral lesion is critical in establishing the diagnosis, the historical and descriptive characteristics of the lesion provided by the patient (eg, location, duration, enlargement, associated pain) enhance the clinician's diagnostic accuracy. (See
         <a class="local">
          'Initial evaluation for all patients with oral lesions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Normal variants of oral mucosa
         </strong>
         – It is important to recognize that several apparent mucosal "abnormalities," such as leukoedema  (
         <a class="graphic graphic_picture graphicRef86890" href="/z/d/graphic/86890.html" rel="external">
          picture 2
         </a>
         ), Fordyce spots  (
         <a class="graphic graphic_picture graphicRef69406 graphicRef66778" href="/z/d/graphic/69406.html" rel="external">
          picture 3B-C
         </a>
         ), and physiologic pigmentation  (
         <a class="graphic graphic_picture graphicRef118581" href="/z/d/graphic/118581.html" rel="external">
          picture 4
         </a>
         ), are actually normal variants and require no further evaluation or treatment. (See
         <a class="local">
          'Normal variants of oral mucosa'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          White and red lesions
         </strong>
         – White or red oral lesions include (see
         <a class="local">
          'White and red oral lesions'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Benign lesions
         </strong>
         – Morsicatio buccarum  (
         <a class="graphic graphic_picture graphicRef118299 graphicRef118584" href="/z/d/graphic/118299.html" rel="external">
          picture 5A-B
         </a>
         ), frictional keratosis  (
         <a class="graphic graphic_picture graphicRef119587" href="/z/d/graphic/119587.html" rel="external">
          picture 6B
         </a>
         ), white sponge nevus  (
         <a class="graphic graphic_picture graphicRef86948" href="/z/d/graphic/86948.html" rel="external">
          picture 22
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Benign lesions with malignant potential
         </strong>
         – Erythroplakia  (
         <a class="graphic graphic_picture graphicRef87511" href="/z/d/graphic/87511.html" rel="external">
          picture 15
         </a>
         ), leukoplakia  (
         <a class="graphic graphic_picture graphicRef81049 graphicRef72711 graphicRef60939" href="/z/d/graphic/81049.html" rel="external">
          picture 13A, 13C, 13E
         </a>
         ), oral lichen planus and other lichenoid lesions  (
         <a class="graphic graphic_picture graphicRef119585 graphicRef76338" href="/z/d/graphic/119585.html" rel="external">
          picture 18A-B
         </a>
         and
         <a class="graphic graphic_picture graphicRef86888 graphicRef86885 graphicRef54143 graphicRef62826" href="/z/d/graphic/86888.html" rel="external">
          picture 19A-C, 19E
         </a>
         ), submucous fibrosis  (
         <a class="graphic graphic_picture graphicRef118287" href="/z/d/graphic/118287.html" rel="external">
          picture 16
         </a>
         and
         <a class="graphic graphic_picture graphicRef118288 graphicRef118289" href="/z/d/graphic/118288.html" rel="external">
          picture 17A-B
         </a>
         ), actinic cheilitis, chronic graft-versus-host disease  (
         <a class="graphic graphic_picture graphicRef73344" href="/z/d/graphic/73344.html" rel="external">
          picture 21B
         </a>
         ), oral lupus erythematosus  (
         <a class="graphic graphic_picture graphicRef118330" href="/z/d/graphic/118330.html" rel="external">
          picture 20
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Malignant lesions
         </strong>
         – Squamous cell carcinoma  (
         <a class="graphic graphic_picture graphicRef81810 graphicRef59057 graphicRef74239" href="/z/d/graphic/81810.html" rel="external">
          picture 12A-C
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Infections
         </strong>
         – Candidiasis  (
         <a class="graphic graphic_picture graphicRef118922 graphicRef79519 graphicRef71723 graphicRef62628 graphicRef89483 graphicRef82214 graphicRef61040 graphicRef75887 graphicRef118243 graphicRef118244" href="/z/d/graphic/118922.html" rel="external">
          picture 7C-D, 9A-B, 10A-F
         </a>
         ), oral hairy leukoplakia  (
         <a class="graphic graphic_picture graphicRef120641" href="/z/d/graphic/120641.html" rel="external">
          picture 11
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pigmented lesions
         </strong>
         – Pigmented lesions of the oral mucosa include (see
         <a class="local">
          'Pigmented lesions'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Melanocytic lesions (typically black or brown)
         </strong>
         – Melanotic macules  (
         <a class="graphic graphic_picture graphicRef112648 graphicRef112649" href="/z/d/graphic/112648.html" rel="external">
          picture 23A-B
         </a>
         ), drug-induced pigmentation, smoker's melanosis, oral melanoacanthoma  (
         <a class="graphic graphic_picture graphicRef118582" href="/z/d/graphic/118582.html" rel="external">
          picture 25
         </a>
         ), melanocytic nevi  (
         <a class="graphic graphic_picture graphicRef118585" href="/z/d/graphic/118585.html" rel="external">
          picture 26
         </a>
         ), oral melanoma  (
         <a class="graphic graphic_picture graphicRef118923" href="/z/d/graphic/118923.html" rel="external">
          picture 27
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Blue/black or gray
         </strong>
         – Amalgam tattoos  (
         <a class="graphic graphic_picture graphicRef130121 graphicRef51720" href="/z/d/graphic/130121.html" rel="external">
          picture 28A-B
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Erosive/ulcerative/bullous lesions
         </strong>
         – Erosive, ulcerative, and bullous oral lesions are very common, with a broad differential diagnosis including infectious, autoimmune, and inflammatory processes. The lesions may appear different depending upon the time of evaluation of the lesion; thus, the clinical history is particularly important to elicit. Ulcerative conditions include (see
         <a class="local">
          'Erosive, ulcerative, and bullous lesions'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Noninfectious aphthous ulcerations
         </strong>
         – Recurrent aphthous stomatitis  (
         <a class="graphic graphic_picture graphicRef63475 graphicRef114283 graphicRef114284" href="/z/d/graphic/63475.html" rel="external">
          picture 29A-C
         </a>
         ), which involves the oral mucosa only; Behçet syndrome  (
         <a class="graphic graphic_picture graphicRef76223" href="/z/d/graphic/76223.html" rel="external">
          picture 30
         </a>
         ); and complex aphthosis (may involve the genital mucosa)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Malignant lesions
         </strong>
         – Squamous cell carcinoma  (
         <a class="graphic graphic_picture graphicRef81810 graphicRef59057 graphicRef74239" href="/z/d/graphic/81810.html" rel="external">
          picture 12A-C
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Infections
         </strong>
         – Herpes simplex virus  (
         <a class="graphic graphic_picture graphicRef71764" href="/z/d/graphic/71764.html" rel="external">
          picture 31
         </a>
         ), varicella-zoster virus  (
         <a class="graphic graphic_picture graphicRef51866 graphicRef83137 graphicRef83136" href="/z/d/graphic/51866.html" rel="external">
          picture 32A-C
         </a>
         ), coxsackievirus  (
         <a class="graphic graphic_picture graphicRef58566 graphicRef71314 graphicRef81027 graphicRef52800 graphicRef53423" href="/z/d/graphic/58566.html" rel="external">
          picture 33A-E
         </a>
         ), syphilis  (
         <a class="graphic graphic_picture graphicRef82771 graphicRef66008 graphicRef72680 graphicRef52729" href="/z/d/graphic/82771.html" rel="external">
          picture 34A-D
         </a>
         ), HIV infection
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Immune-mediated ulcerations
         </strong>
         – Erosive lichen planus  (
         <a class="graphic graphic_picture graphicRef62826 graphicRef54143" href="/z/d/graphic/62826.html" rel="external">
          picture 19C, 19E
         </a>
         ), systemic lupus erythematosus  (
         <a class="graphic graphic_picture graphicRef63605" href="/z/d/graphic/63605.html" rel="external">
          picture 35B
         </a>
         ), mucous membrane pemphigoid  (
         <a class="graphic graphic_picture graphicRef77654 graphicRef63997" href="/z/d/graphic/77654.html" rel="external">
          picture 36B-C
         </a>
         ), bullous pemphigoid, pemphigus vulgaris  (
         <a class="graphic graphic_picture graphicRef57924" href="/z/d/graphic/57924.html" rel="external">
          picture 37
         </a>
         ), paraneoplastic pemphigus  (
         <a class="graphic graphic_picture graphicRef59594 graphicRef79518 graphicRef54382" href="/z/d/graphic/59594.html" rel="external">
          picture 38A-C
         </a>
         ), epidermolysis bullosa acquisita, erythema multiforme  (
         <a class="graphic graphic_picture graphicRef58969 graphicRef68153 graphicRef62370" href="/z/d/graphic/58969.html" rel="external">
          picture 39A-C
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Non-immune-mediated ulcerations
         </strong>
         – Epidermolysis bullosa (see
         <a class="medical medical_review" href="/z/d/html/15449.html" rel="external">
          "Epidermolysis bullosa: Epidemiology, pathogenesis, classification, and clinical features"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Drug-induced ulcerations
         </strong>
         – Stevens-Johnson syndrome/toxic epidermal necrolysis  (
         <a class="graphic graphic_picture graphicRef68682 graphicRef73805" href="/z/d/graphic/68682.html" rel="external">
          picture 40A-B
         </a>
         ), mammalian (mechanistic) target of rapamycin (mTOR) inhibitor-associated stomatitis, and nicorandil-induced ulceration
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tongue lesions
         </strong>
         – Tongue lesions include those that are considered normal variants as well as lesions that are abnormal (see
         <a class="local">
          'Tongue lesions'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Normal tongue variants
         </strong>
         – Fissured tongue  (
         <a class="graphic graphic_picture graphicRef85871" href="/z/d/graphic/85871.html" rel="external">
          picture 41B
         </a>
         ), black tongue  (
         <a class="graphic graphic_picture graphicRef67179" href="/z/d/graphic/67179.html" rel="external">
          picture 42
         </a>
         ), pigmented fungiform papillae  (
         <a class="graphic graphic_picture graphicRef93385" href="/z/d/graphic/93385.html" rel="external">
          picture 43
         </a>
         ) (see
         <a class="local">
          'Normal tongue variants'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Abnormal tongue lesions
         </strong>
         – Atrophic glossitis  (
         <a class="graphic graphic_picture graphicRef85872 graphicRef54472" href="/z/d/graphic/85872.html" rel="external">
          picture 44A-B
         </a>
         ), black hairy tongue  (
         <a class="graphic graphic_picture graphicRef76664" href="/z/d/graphic/76664.html" rel="external">
          picture 45
         </a>
         ), geographic tongue  (
         <a class="graphic graphic_picture graphicRef74654 graphicRef79512" href="/z/d/graphic/74654.html" rel="external">
          picture 46A-B
         </a>
         ), median rhomboid glossitis  (
         <a class="graphic graphic_picture graphicRef118589 graphicRef118243 graphicRef118244" href="/z/d/graphic/118589.html" rel="external">
          picture 9A-C
         </a>
         ), granular cell tumor  (
         <a class="graphic graphic_picture graphicRef100363" href="/z/d/graphic/100363.html" rel="external">
          picture 47
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Miscellaneous lesions
         </strong>
         – A variety of other lesions can occur in the mouth and oral mucous membranes. These include cheilitis  (
         <a class="graphic graphic_picture graphicRef54887" href="/z/d/graphic/54887.html" rel="external">
          picture 49
         </a>
         ), mucoceles  (
         <a class="graphic graphic_picture graphicRef70332 graphicRef75671" href="/z/d/graphic/70332.html" rel="external">
          picture 50A-B
         </a>
         ), torus palatinus  (
         <a class="graphic graphic_picture graphicRef94936" href="/z/d/graphic/94936.html" rel="external">
          picture 52
         </a>
         ) and mandibularis, tumors of the minor salivary glands, gingival overgrowth  (
         <a class="graphic graphic_picture graphicRef82641" href="/z/d/graphic/82641.html" rel="external">
          picture 53
         </a>
         ), telangiectasias secondary to hereditary hemorrhagic telangiectasia  (
         <a class="graphic graphic_picture graphicRef96711 graphicRef96712" href="/z/d/graphic/96711.html" rel="external">
          picture 55A-B
         </a>
         ), and contact stomatitis  (
         <a class="graphic graphic_picture graphicRef58869" href="/z/d/graphic/58869.html" rel="external">
          picture 56
         </a>
         ). (See
         <a class="local">
          'Miscellaneous oral lesions'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/13654.html" rel="external">
          "Cheilitis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1345.html" rel="external">
          "Clinical manifestations and diagnosis of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3352425054">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Adam O Goldstein, MD, MPH, and Beth G Goldstein, MD, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Papadiochou S, Papadiochos I, Perisanidis C, Papadogeorgakis N. Medical practitioners' educational competence about oral and oropharyngeal carcinoma: a systematic review and meta-analysis. Br J Oral Maxillofac Surg 2020; 58:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morgan R, Tsang J, Harrington N, Fook L. Survey of hospital doctors' attitudes and knowledge of oral conditions in older patients. Postgrad Med J 2001; 77:392.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moyer VA, U.S. Preventive Services Task Force. Screening for oral cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014; 160:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lim K, Moles DR, Downer MC, Speight PM. Opportunistic screening for oral cancer and precancer in general dental practice: results of a demonstration study. Br Dent J 2003; 194:497.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Speight PM, Palmer S, Moles DR, et al. The cost-effectiveness of screening for oral cancer in primary care. Health Technol Assess 2006; 10:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maymone MBC, Greer RO, Kesecker J, et al. Premalignant and malignant oral mucosal lesions: Clinical and pathological findings. J Am Acad Dermatol 2019; 81:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maymone MBC, Greer RO, Burdine LK, et al. Benign oral mucosal lesions: Clinical and pathological findings. J Am Acad Dermatol 2019; 81:43.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Madani M, Berardi T, Stoopler ET. Anatomic and examination considerations of the oral cavity. Med Clin North Am 2014; 98:1225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Madani FM, Kuperstein AS. Normal variations of oral anatomy and common oral soft tissue lesions: evaluation and management. Med Clin North Am 2014; 98:1281.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martin JL. Leukoedema: an epidemiological study in white and African Americans. J Tenn Dent Assoc 1997; 77:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martin JL. Leukoedema: a review of the literature. J Natl Med Assoc 1992; 84:938.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meleti M, Vescovi P, Mooi WJ, van der Waal I. Pigmented lesions of the oral mucosa and perioral tissues: a flow-chart for the diagnosis and some recommendations for the management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 105:606.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kauzman A, Pavone M, Blanas N, Bradley G. Pigmented lesions of the oral cavity: review, differential diagnosis, and case presentations. J Can Dent Assoc 2004; 70:682.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hassona Y, Sawair F, Al-Karadsheh O, Scully C. Prevalence and clinical features of pigmented oral lesions. Int J Dermatol 2016; 55:1005.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Woo SB, Lin D. Morsicatio mucosae oris--a chronic oral frictional keratosis, not a leukoplakia. J Oral Maxillofac Surg 2009; 67:140.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Natarajan E, Woo SB. Benign alveolar ridge keratosis (oral lichen simplex chronicus): A distinct clinicopathologic entity. J Am Acad Dermatol 2008; 58:151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bellato L, Martinelli-Kläy CP, Martinelli CR, Lombardi T. Alveolar ridge keratosis--a retrospective clinicopathological study. Head Face Med 2013; 9:12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Millsop JW, Fazel N. Oral candidiasis. Clin Dermatol 2016; 34:487.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akpan A, Morgan R. Oral candidiasis. Postgrad Med J 2002; 78:455.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kanli A, Demirel F, Sezgin Y. Oral candidosis, denture cleanliness and hygiene habits in an elderly population. Aging Clin Exp Res 2005; 17:502.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shanahan D, Cowie R, Rogers H, Staines K. Oral hairy leukoplakia in healthy immunocompetent patients: a small case series. Oral Maxillofac Surg 2018; 22:335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ellington TD, Henley SJ, Senkomago V, et al. Trends in Incidence of Cancers of the Oral Cavity and Pharynx - United States 2007-2016. MMWR Morb Mortal Wkly Rep 2020; 69:433.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kalavrezos N, Scully C. Mouth Cancer for Clinicians Part 6: Potentially Malignant Disorders. Dent Update 2015; 42:866.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol 2017; 3:524.
          </a>
         </li>
         <li class="breakAll">
          https://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf (Accessed on January 14, 2019).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shield KD, Ferlay J, Jemal A, et al. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA Cancer J Clin 2017; 67:51.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin 2021; 71:7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hashibe M, Brennan P, Chuang SC, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 2009; 18:541.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Voltzke KJ, Lee YA, Zhang ZF, et al. Racial differences in the relationship between tobacco, alcohol, and the risk of head and neck cancer: pooled analysis of US studies in the INHANCE Consortium. Cancer Causes Control 2018; 29:619.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Toporcov TN, Znaor A, Zhang ZF, et al. Risk factors for head and neck cancer in young adults: a pooled analysis in the INHANCE consortium. Int J Epidemiol 2015; 44:169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Combes JD, Franceschi S. Role of human papillomavirus in non-oropharyngeal head and neck cancers. Oral Oncol 2014; 50:370.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vidal Loustau AC, Dulguerov N, Curvoisier D, et al. Low prevalence of HPV-induced oral squamous cell carcinoma in Geneva, Switzerland. Oral Dis 2019; 25:1283.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krüger M, Pabst AM, Walter C, et al. The prevalence of human papilloma virus (HPV) infections in oral squamous cell carcinomas: a retrospective analysis of 88 patients and literature overview. J Craniomaxillofac Surg 2014; 42:1506.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mccormick NJ, Thomson PJ, Carrozzo M. The Clinical Presentation of Oral Potentially Malignant Disorders. Prim Dent J 2016; 5:52.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wetzel SL, Wollenberg J. Oral Potentially Malignant Disorders. Dent Clin North Am 2020; 64:25.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, et al. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis 2021; 27:1862.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mello FW, Miguel AFP, Dutra KL, et al. Prevalence of oral potentially malignant disorders: A systematic review and meta-analysis. J Oral Pathol Med 2018; 47:633.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Iocca O, Sollecito TP, Alawi F, et al. Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype. Head Neck 2020; 42:539.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gillenwater AM, Vigneswaran N, Fatani H, et al. Proliferative verrucous leukoplakia (PVL): a review of an elusive pathologic entity! Adv Anat Pathol 2013; 20:416.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bagan J, Scully C, Jimenez Y, Martorell M. Proliferative verrucous leukoplakia: a concise update. Oral Dis 2010; 16:328.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pentenero M, Meleti M, Vescovi P, Gandolfo S. Oral proliferative verrucous leucoplakia: are there particular features for such an ambiguous entity? A systematic review. Br J Dermatol 2014; 170:1039.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holmstrup P. Oral erythroplakia-What is it? Oral Dis 2018; 24:138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chuang SL, Wang CP, Chen MK, et al. Malignant transformation to oral cancer by subtype of oral potentially malignant disorder: A prospective cohort study of Taiwanese nationwide oral cancer screening program. Oral Oncol 2018; 87:58.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yang SW, Lee YS, Chang LC, et al. Outcome of excision of oral erythroplakia. Br J Oral Maxillofac Surg 2015; 53:142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Passi D, Bhanot P, Kacker D, et al. Oral submucous fibrosis: Newer proposed classification with critical updates in pathogenesis and management strategies. Natl J Maxillofac Surg 2017; 8:89.
          </a>
         </li>
         <li class="breakAll">
          International Agency for Research on Cancer. Betel quid and areca nut. In: Personal habits and indoor combustions. Vol 100 E. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum 2012; 100(part E): 1-538. https://monographs.iarc.fr/ENG/Monographs/vol100E/mono100E-10.pdf (Accessed on June 28, 2018).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ali FM, Patil A, Patil K, Prasant MC. Oral submucous fibrosis and its dermatological relation. Indian Dermatol Online J 2014; 5:260.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khudhur AS, Di Zenzo G, Carrozzo M. Oral lichenoid tissue reactions: diagnosis and classification. Expert Rev Mol Diagn 2014; 14:169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Müller S. Oral lichenoid lesions: distinguishing the benign from the deadly. Mod Pathol 2017; 30:S54.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fitzpatrick SG, Hirsch SA, Gordon SC. The malignant transformation of oral lichen planus and oral lichenoid lesions: a systematic review. J Am Dent Assoc 2014; 145:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lourenço SV, de Carvalho FR, Boggio P, et al. Lupus erythematosus: clinical and histopathological study of oral manifestations and immunohistochemical profile of the inflammatory infiltrate. J Cutan Pathol 2007; 34:558.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sultan SM, Ioannou Y, Isenberg DA. A review of gastrointestinal manifestations of systemic lupus erythematosus. Rheumatology (Oxford) 1999; 38:917.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lourenço SV, Nacagami Sotto M, Constantino Vilela MA, et al. Lupus erythematosus: clinical and histopathological study of oral manifestations and immunohistochemical profile of epithelial maturation. J Cutan Pathol 2006; 33:657.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Urman JD, Lowenstein MB, Abeles M, Weinstein A. Oral mucosal ulceration in systemic lupus erythematosus. Arthritis Rheum 1978; 21:58.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ranginwala AM, Chalishazar MM, Panja P, et al. Oral discoid lupus erythematosus: A study of twenty-one cases. J Oral Maxillofac Pathol 2012; 16:368.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jagasia MH, Greinix HT, Arora M, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 2015; 21:389.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Margaix-Muñoz M, Bagán JV, Jiménez Y, et al. Graft-versus-host disease affecting oral cavity. A review. J Clin Exp Dent 2015; 7:e138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mays JW, Fassil H, Edwards DA, et al. Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research. Oral Dis 2013; 19:327.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Atsuta Y, Suzuki R, Yamashita T, et al. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease. Ann Oncol 2014; 25:435.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rugg EL, McLean WH, Allison WE, et al. A mutation in the mucosal keratin K4 is associated with oral white sponge nevus. Nat Genet 1995; 11:450.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Richard G, De Laurenzi V, Didona B, et al. Keratin 13 point mutation underlies the hereditary mucosal epithelial disorder white sponge nevus. Nat Genet 1995; 11:453.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Otobe IF, de Sousa SO, Matthews RW, Migliari DA. White sponge naevus: improvement with tetracycline mouth rinse: report of four cases. Clin Exp Dermatol 2007; 32:749.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McDonagh AJ, Gawkrodger DJ, Walker AE. White sponge naevus successfully treated with topical tetracycline. Clin Exp Dermatol 1990; 15:152.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaugars GE, Heise AP, Riley WT, et al. Oral melanotic macules. A review of 353 cases. Oral Surg Oral Med Oral Pathol 1993; 76:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yuan A, Woo SB. Adverse drug events in the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol 2015; 119:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tarakji B, Umair A, Prasad D, Alsakran Altamimi M. Diagnosis of oral pigmentations and malignant transformations. Singapore Dent J 2014; 35C:39.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taybos G. Oral changes associated with tobacco use. Am J Med Sci 2003; 326:179.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Naveen-Kumar B, Tatapudi R, Sudhakara-Reddy R, et al. Various forms of tobacco usage and its associated oral mucosal lesions. J Clin Exp Dent 2016; 8:e172.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alawi F. Pigmented lesions of the oral cavity: an update. Dent Clin North Am 2013; 57:699.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Notani K, Shindoh M, Yamazaki Y, et al. Amelanotic malignant melanomas of the oral mucosa. Br J Oral Maxillofac Surg 2002; 40:195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Owens BM, Johnson WW, Schuman NJ. Oral amalgam pigmentations (tattoos): a retrospective study. Quintessence Int 1992; 23:805.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Edgar NR, Saleh D, Miller RA. Recurrent Aphthous Stomatitis: A Review. J Clin Aesthet Dermatol 2017; 10:26.
          </a>
         </li>
         <li class="breakAll">
          Lodi G, Varoni E, Robledo-Sierra J, et al. Oral ulcerative lesions. In: Contemporary Oral Medicine, Farah C, Balasubramaniam R, McCullough M (Eds), Springer, 2017.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet 1990; 335:1078.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCarty MA, Garton RA, Jorizzo JL. Complex aphthosis and Behçet's disease. Dermatol Clin 2003; 21:41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jorizzo JL, Taylor RS, Schmalstieg FC, et al. Complex aphthosis: a forme fruste of Behçet's syndrome? J Am Acad Dermatol 1985; 13:80.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaneko Y, Nakai N, Kida T, et al. Mouth and Genital Ulcers with Inflamed Cartilage Syndrome: Case Report and Review of the Published Work. Indian J Dermatol 2016; 61:347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burton MJ, Pollard AJ, Ramsden JD, et al. Tonsillectomy for periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA). Cochrane Database Syst Rev 2014; :CD008669.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Balasubramaniam R, Kuperstein AS, Stoopler ET. Update on oral herpes virus infections. Dent Clin North Am 2014; 58:265.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wauters O, Lebas E, Nikkels AF. Chronic mucocutaneous herpes simplex virus and varicella zoster virus infections. J Am Acad Dermatol 2012; 66:e217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liermann K, Schäfler A, Henke A, Sauerbrei A. Evaluation of commercial herpes simplex virus IgG and IgM enzyme immunoassays. J Virol Methods 2014; 199:29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramírez-Amador V, Esquivel-Pedraza L, Sierra-Madero J, et al. The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients: A 12-Year Study in a Referral Center in Mexico. Medicine (Baltimore) 2003; 82:39.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taiwo OO, Hassan Z. The impact of Highly Active Antiretroviral Therapy (HAART) on the clinical features of HIV - related oral lesions in Nigeria. AIDS Res Ther 2010; 7:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hamza OJ, Matee MI, Simon EN, et al. Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy [HAART] in Dar es Salaam, Tanzania. BMC Oral Health 2006; 6:12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reichart PA. Oral ulcerations in HIV infection. Oral Dis 1997; 3 Suppl 1:S180.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alegre M, Dalmau J, Domingo P, et al. Successful treatment of major oral aphthous ulcers in HIV-1 infection after highly active antiretroviral therapy. Int J Infect Dis 2007; 11:278.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Delgado WA, Romero de Leon E. 14th International Congress IAOP/AAOMP Clinical Pathology Conference Case 6. Head Neck Pathol 2008; 2:298.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Doni BR, Peerapur BV, Thotappa LH, Hippargi SB. Sequence of oral manifestations in rhino-maxillary mucormycosis. Indian J Dent Res 2011; 22:331.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Limper AH, Adenis A, Le T, Harrison TS. Fungal infections in HIV/AIDS. Lancet Infect Dis 2017; 17:e334.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deepa A, Nair BJ, Sivakumar T, Joseph AP. Uncommon opportunistic fungal infections of oral cavity: A review. J Oral Maxillofac Pathol 2014; 18:235.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Telles DR, Karki N, Marshall MW. Oral Fungal Infections: Diagnosis and Management. Dent Clin North Am 2017; 61:319.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Irani S, Monsef Esfahani A, Bidari Zerehpoush F. Detection of Helicobacter pylori in Oral Lesions. J Dent Res Dent Clin Dent Prospects 2013; 7:230.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arduino PG, Broccoletti R, Carbone M, et al. Describing the gingival involvement in a sample of 182 Italian predominantly oral mucous membrane pemphigoid patients: A retrospective series. Med Oral Patol Oral Cir Bucal 2017; 22:e149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bagan J, Jiménez Y, Murillo J, Bagan L. Oral mucous membrane pemphigoid: A clinical study of 100 low-risk cases. Oral Dis 2018; 24:132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frew JW, Murrell DF. Paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome): clinical presentations and pathogenesis. Dermatol Clin 2011; 29:419.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anhalt GJ. Paraneoplastic pemphigus. J Investig Dermatol Symp Proc 2004; 9:29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Billet SE, Grando SA, Pittelkow MR. Paraneoplastic autoimmune multiorgan syndrome: review of the literature and support for a cytotoxic role in pathogenesis. Autoimmunity 2006; 39:617.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sokumbi O, Wetter DA. Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist. Int J Dermatol 2012; 51:889.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lo Muzio L, Arena C, Troiano G, Villa A. Oral stomatitis and mTOR inhibitors: A review of current evidence in 20,915 patients. Oral Dis 2018; 24:144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sonis S, Treister N, Chawla S, et al. Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients. Cancer 2010; 116:210.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Oliveira MA, Martins E Martins F, Wang Q, et al. Clinical presentation and management of mTOR inhibitor-associated stomatitis. Oral Oncol 2011; 47:998.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Villa A, Aboalela A, Luskin KA, et al. Mammalian target of rapamycin inhibitor-associated stomatitis in hematopoietic stem cell transplantation patients receiving sirolimus prophylaxis for graft-versus-host disease. Biol Blood Marrow Transplant 2015; 21:503.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shazib MA, Woo SB, Sroussi H, et al. Oral immune-related adverse events associated with PD-1 inhibitor therapy: A case series. Oral Dis 2020; 26:325.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Srivastava A, Al-Zubidi N, Appelbaum E, et al. Immune-Related Oral, Otologic, and Ocular Adverse Events. Adv Exp Med Biol 2020; 1244:295.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee MT, Lin HY, Lee SH, et al. Risk of skin ulcerations associated with oral nicorandil therapy: a population-based study. Br J Dermatol 2015; 173:498.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Webster K, Godbold P. Nicorandil induced oral ulceration. Br Dent J 2005; 198:619.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marquart-Elbaz C, Lipsker D, Grosshans E, Cribier B. [Oral ulcers induced by nicorandil: prevalence and clinicopathological aspects]. Ann Dermatol Venereol 1999; 126:587.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McGettigan P, Ferner RE. Painful perianal ulcers with nicorandil. BMJ 2020; 370:m3351.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yamamoto K, Matsusue Y, Horita S, et al. Nicorandil-induced oral ulceration: report of 3 cases and review of the Japanese literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011; 112:754.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scully C, Azul AM, Crighton A, et al. Nicorandil can induce severe oral ulceration. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 91:189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Daneshpazhooh M, Nazemi TM, Bigdeloo L, Yoosefi M. Mucocutaneous findings in 100 children with Down syndrome. Pediatr Dermatol 2007; 24:317.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rose AE, Leger M, Chu J, Meehan S. Cheilitis granulomatosa. Dermatol Online J 2011; 17:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jover-Diaz F, Cuadrado-Pastor JM, Talents-Bolos A, Martin-Gonzalez C. Black tongue associated with linezolid. Am J Ther 2010; 17:e115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guinovart RM, Carrascosa JM, Bielsa I, et al. A black tongue in a young woman. Clin Exp Dermatol 2011; 36:429.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen PR. Black tongue secondary to bismuth subsalicylate: case report and review of exogenous causes of macular lingual pigmentation. J Drugs Dermatol 2009; 8:1132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ma DL, Vano-Galvan S. Hyperpigmentation in Laugier-Hunziker syndrome. CMAJ 2011; 183:1402.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akcaboy M, Sahin S, Zorlu P, Şenel S. Ranitidine-induced black tongue: A case report. Pediatr Dermatol 2017; 34:e334.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holzwanger JM, Rudolph RI, Heaton CL. Pigmented fungiform papillae of the tongue: a common variant of oral pigmentation. Int J Dermatol 1974; 13:403.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Romiti R, Molina De Medeiros L. Pigmented fungiform papillae of the tongue. Pediatr Dermatol 2010; 27:398.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Werchniak AE, Storm CA, Dinulos JG. Hyperpigmented patches on the tongue of a young girl. Pigmented fungiform papillae of the tongue. Arch Dermatol 2004; 140:1275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Al-Fagaan F, Joseph B. A case of pigmented fungiform papillae of the tongue in a Middle Eastern woman. Med Princ Pract 2014; 23:167.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reamy BV, Derby R, Bunt CW. Common tongue conditions in primary care. Am Fam Physician 2010; 81:627.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pastore L, Carroccio A, Compilato D, et al. Oral manifestations of celiac disease. J Clin Gastroenterol 2008; 42:224.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bøhmer T, Mowé M. The association between atrophic glossitis and protein-calorie malnutrition in old age. Age Ageing 2000; 29:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sarti GM, Haddy RI, Schaffer D, Kihm J. Black hairy tongue. Am Fam Physician 1990; 41:1751.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schlager E, St Claire C, Ashack K, Khachemoune A. Black Hairy Tongue: Predisposing Factors, Diagnosis, and Treatment. Am J Clin Dermatol 2017; 18:563.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Assimakopoulos D, Patrikakos G, Fotika C, Elisaf M. Benign migratory glossitis or geographic tongue: an enigmatic oral lesion. Am J Med 2002; 113:751.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sigal MJ, Mock D. Symptomatic benign migratory glossitis: report of two cases and literature review. Pediatr Dent 1992; 14:392.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brooks JK, Balciunas BA. Geographic stomatitis: review of the literature and report of five cases. J Am Dent Assoc 1987; 115:421.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ishibashi M, Tojo G, Watanabe M, et al. Geographic tongue treated with topical tacrolimus. J Dermatol Case Rep 2010; 4:57.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goregen M, Miloglu O, Buyukkurt MC, et al. Median rhomboid glossitis: a clinical and microbiological study. Eur J Dent 2011; 5:367.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Panta P, Erugula SR. Median rhomboid glossitis-developmental or candidal? Pan Afr Med J 2015; 21:221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vaughan V, Ferringer T. Granular cell tumor. Cutis 2014; 94:275, 279.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van de Loo S, Thunnissen E, Postmus P, van der Waal I. Granular cell tumor of the oral cavity; a case series including a case of metachronous occurrence in the tongue and the lung. Med Oral Patol Oral Cir Bucal 2015; 20:e30.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Valdec S, Stadlinger B. Mucocoele of the lower lip. CMAJ 2023; 195:E1125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chi AC, Lambert PR 3rd, Richardson MS, Neville BW. Oral mucoceles: a clinicopathologic review of 1,824 cases, including unusual variants. J Oral Maxillofac Surg 2011; 69:1086.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Re Cecconi D, Achilli A, Tarozzi M, et al. Mucoceles of the oral cavity: a large case series (1994-2008) and a literature review. Med Oral Patol Oral Cir Bucal 2010; 15:e551.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hong CHL, Dean DR, Hull K, et al. World Workshop on Oral Medicine VII: Relative frequency of oral mucosal lesions in children, a scoping review. Oral Dis 2019; 25 Suppl 1:193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mínguez-Martinez I, Bonet-Coloma C, Ata-Ali-Mahmud J, et al. Clinical characteristics, treatment, and evolution of 89 mucoceles in children. J Oral Maxillofac Surg 2010; 68:2468.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huang IY, Chen CM, Kao YH, Worthington P. Treatment of mucocele of the lower lip with carbon dioxide laser. J Oral Maxillofac Surg 2007; 65:855.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sinha R, Sarkar S, Khaitan T, et al. Nonsurgical Management of Oral Mucocele by Intralesional Corticosteroid Therapy. Int J Dent 2016; 2016:2896748.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ladizinski B, Lee KC. A nodular protuberance on the hard palate. JAMA 2014; 311:1558.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Loukas M, Hulsberg P, Tubbs RS, et al. The tori of the mouth and ear: a review. Clin Anat 2013; 26:953.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           García-García AS, Martínez-González JM, Gómez-Font R, et al. Current status of the torus palatinus and torus mandibularis. Med Oral Patol Oral Cir Bucal 2010; 15:e353.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Al-Bayaty HF, Murti PR, Matthews R, Gupta PC. An epidemiological study of tori among 667 dental outpatients in Trinidad &amp; Tobago, West Indies. Int Dent J 2001; 51:300.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jainkittivong A, Langlais RP. Buccal and palatal exostoses: prevalence and concurrence with tori. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 90:48.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bruce I, Ndanu TA, Addo ME. Epidemiological aspects of oral tori in a Ghanaian community. Int Dent J 2004; 54:78.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morita K, Tsuka H, Shintani T, et al. Prevalence of Torus Mandibularis in Young Healthy Dentate Adults. J Oral Maxillofac Surg 2017; 75:2593.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ellis JS, Seymour RA, Thomason JM, et al. Gingival sequestration of amlodipine and amlodipine-induced gingival overgrowth. Lancet 1993; 341:1102.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steele RM, Schuna AA, Schreiber RT. Calcium antagonist-induced gingival hyperplasia. Ann Intern Med 1994; 120:663.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lakkam BD, Astekar M, Alam S, et al. Relative frequency of oral focal reactive overgrowths: An institutional retrospective study. J Oral Maxillofac Pathol 2020; 24:76.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olitsky SE. Picture of the month. Telangiectases secondary to hereditary hemorrhagic telangiectasia. Arch Pediatr Adolesc Med 2011; 165:275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shovlin CL. Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev 2010; 24:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cifuentes M, Davari P, Rogers RS 3rd. Contact stomatitis. Clin Dermatol 2017; 35:435.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Visconti MJ, Ashack KA. Dermatologic manifestations associated with electronic cigarette use. J Am Acad Dermatol 2019; 81:1001.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5572 Version 55.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31785865" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Medical practitioners' educational competence about oral and oropharyngeal carcinoma: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11375454" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Survey of hospital doctors' attitudes and knowledge of oral conditions in older patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24276469" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Screening for oral cancer: U.S. Preventive Services Task Force recommendation statement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12835785" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Opportunistic screening for oral cancer and precancer in general dental practice: results of a demonstration study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16707071" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : The cost-effectiveness of screening for oral cancer in primary care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30447325" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Premalignant and malignant oral mucosal lesions: Clinical and pathological findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30447312" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Benign oral mucosal lesions: Clinical and pathological findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25443674" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Anatomic and examination considerations of the oral cavity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25443677" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Normal variations of oral anatomy and common oral soft tissue lesions: evaluation and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9520752" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Leukoedema: an epidemiological study in white and African Americans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1460680" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Leukoedema: a review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18206403" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Pigmented lesions of the oral mucosa and perioral tissues: a flow-chart for the diagnosis and some recommendations for the management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15530266" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Pigmented lesions of the oral cavity: review, differential diagnosis, and case presentations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26711197" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Prevalence and clinical features of pigmented oral lesions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19070760" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Morsicatio mucosae oris--a chronic oral frictional keratosis, not a leukoplakia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18158926" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Benign alveolar ridge keratosis (oral lichen simplex chronicus): A distinct clinicopathologic entity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23587097" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Alveolar ridge keratosis--a retrospective clinicopathological study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27343964" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Oral candidiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12185216" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Oral candidiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16485869" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Oral candidosis, denture cleanliness and hygiene habits in an elderly population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30079439" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Oral hairy leukoplakia in healthy immunocompetent patients: a small case series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32298244" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Trends in Incidence of Cancers of the Oral Cavity and Pharynx - United States 2007-2016.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26749794" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Mouth Cancer for Clinicians Part 6: Potentially Malignant Disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27918777" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27918777" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28076666" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33433946" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Cancer Statistics, 2021.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19190158" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29761303" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Racial differences in the relationship between tobacco, alcohol, and the risk of head and neck cancer: pooled analysis of US studies in the INHANCE Consortium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25613428" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Risk factors for head and neck cancer in young adults: a pooled analysis in the INHANCE consortium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24331868" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Role of human papillomavirus in non-oropharyngeal head and neck cancers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30839148" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Low prevalence of HPV-induced oral squamous cell carcinoma in Geneva, Switzerland.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24947612" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : The prevalence of human papilloma virus (HPV) infections in oral squamous cell carcinomas: a retrospective analysis of 88 patients and literature overview.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29029654" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : The Clinical Presentation of Oral Potentially Malignant Disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31735231" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Oral Potentially Malignant Disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33128420" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29738071" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Prevalence of oral potentially malignant disorders: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31803979" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24113312" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Proliferative verrucous leukoplakia (PVL): a review of an elusive pathologic entity!
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20233330" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Proliferative verrucous leukoplakia: a concise update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24471527" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Oral proliferative verrucous leucoplakia: are there particular features for such an ambiguous entity? A systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29480616" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Oral erythroplakia-What is it?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30527244" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Malignant transformation to oral cancer by subtype of oral potentially malignant disorder: A prospective cohort study of Taiwanese nationwide oral cancer screening program.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25467247" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Outcome of excision of oral erythroplakia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29386809" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Oral submucous fibrosis: Newer proposed classification with critical updates in pathogenesis and management strategies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29386809" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Oral submucous fibrosis: Newer proposed classification with critical updates in pathogenesis and management strategies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25165640" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Oral submucous fibrosis and its dermatological relation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24524807" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Oral lichenoid tissue reactions: diagnosis and classification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28060366" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Oral lichenoid lesions: distinguishing the benign from the deadly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24379329" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : The malignant transformation of oral lichen planus and oral lichenoid lesions: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17576335" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Lupus erythematosus: clinical and histopathological study of oral manifestations and immunohistochemical profile of the inflammatory infiltrate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10534541" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : A review of gastrointestinal manifestations of systemic lupus erythematosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17026516" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Lupus erythematosus: clinical and histopathological study of oral manifestations and immunohistochemical profile of epithelial maturation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/623694" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Oral mucosal ulceration in systemic lupus erythematosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23248469" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Oral discoid lupus erythematosus: A study of twenty-one cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25529383" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25810826" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Graft-versus-host disease affecting oral cavity. A review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23107104" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24399081" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7493030" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : A mutation in the mucosal keratin K4 is associated with oral white sponge nevus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7493031" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Keratin 13 point mutation underlies the hereditary mucosal epithelial disorder white sponge nevus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17725655" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : White sponge naevus: improvement with tetracycline mouth rinse: report of four cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2347109" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : White sponge naevus successfully treated with topical tetracycline.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8351123" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Oral melanotic macules. A review of 353 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25442252" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Adverse drug events in the oral cavity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25496584" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Diagnosis of oral pigmentations and malignant transformations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14557730" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Oral changes associated with tobacco use.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27034758" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Various forms of tobacco usage and its associated oral mucosal lesions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24034073" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Pigmented lesions of the oral cavity: an update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12054708" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Amelanotic malignant melanomas of the oral mucosa.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1305297" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Oral amalgam pigmentations (tattoos): a retrospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28360966" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Recurrent Aphthous Stomatitis: A Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28360966" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Recurrent Aphthous Stomatitis: A Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1970380" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12622267" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Complex aphthosis and Behçet's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4031155" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Complex aphthosis: a forme fruste of Behçet's syndrome?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27293269" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Mouth and Genital Ulcers with Inflamed Cartilage Syndrome: Case Report and Review of the Published Work.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25209127" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Tonsillectomy for periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24655522" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Update on oral herpes virus infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21056516" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Chronic mucocutaneous herpes simplex virus and varicella zoster virus infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24418499" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Evaluation of commercial herpes simplex virus IgG and IgM enzyme immunoassays.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12544709" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients: A 12-Year Study in a Referral Center in Mexico.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20579347" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : The impact of Highly Active Antiretroviral Therapy (HAART) on the clinical features of HIV - related oral lesions in Nigeria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16916469" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy [HAART] in Dar es Salaam, Tanzania.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9456685" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Oral ulcerations in HIV infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16857406" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Successful treatment of major oral aphthous ulcers in HIV-1 infection after highly active antiretroviral therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20614298" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : 14th International Congress IAOP/AAOMP Clinical Pathology Conference Case 6.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21891908" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Sequence of oral manifestations in rhino-maxillary mucormycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28774701" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Fungal infections in HIV/AIDS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25328305" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Uncommon opportunistic fungal infections of oral cavity: A review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28317569" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Oral Fungal Infections: Diagnosis and Management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24578822" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Detection of Helicobacter pylori in Oral Lesions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28160581" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Describing the gingival involvement in a sample of 182 Italian predominantly oral mucous membrane pemphigoid patients: A retrospective series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29480624" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Oral mucous membrane pemphigoid: A clinical study of 100 low-risk cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21605807" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome): clinical presentations and pathogenesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14870982" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Paraneoplastic pemphigus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17101506" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Paraneoplastic autoimmune multiorgan syndrome: review of the literature and support for a cytotoxic role in pathogenesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22788803" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29480626" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Oral stomatitis and mTOR inhibitors: A review of current evidence in 20,915 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19862817" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21890398" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Clinical presentation and management of mTOR inhibitor-associated stomatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25482865" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Mammalian target of rapamycin inhibitor-associated stomatitis in hematopoietic stem cell transplantation patients receiving sirolimus prophylaxis for graft-versus-host disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31642136" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Oral immune-related adverse events associated with PD-1 inhibitor therapy: A case series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32301024" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Immune-Related Oral, Otologic, and Ocular Adverse Events.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25939634" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Risk of skin ulcerations associated with oral nicorandil therapy: a population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15920586" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Nicorandil induced oral ulceration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10530345" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : [Oral ulcers induced by nicorandil: prevalence and clinicopathological aspects].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32933904" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Painful perianal ulcers with nicorandil.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21872503" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Nicorandil-induced oral ulceration: report of 3 cases and review of the Japanese literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11174596" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Nicorandil can induce severe oral ulceration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17542890" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Mucocutaneous findings in 100 children with Down syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22031641" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Cheilitis granulomatosa.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20634649" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Black tongue associated with linezolid.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21564183" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : A black tongue in a young woman.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20027942" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Black tongue secondary to bismuth subsalicylate: case report and review of exogenous causes of macular lingual pigmentation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21825050" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Hyperpigmentation in Laugier-Hunziker syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28967681" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Ranitidine-induced black tongue: A case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4430531" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Pigmented fungiform papillae of the tongue: a common variant of oral pigmentation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20653864" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Pigmented fungiform papillae of the tongue.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15492194" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Hyperpigmented patches on the tongue of a young girl. Pigmented fungiform papillae of the tongue.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24246640" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : A case of pigmented fungiform papillae of the tongue in a Middle Eastern woman.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20187599" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Common tongue conditions in primary care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18223505" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Oral manifestations of celiac disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10690695" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : The association between atrophic glossitis and protein-calorie malnutrition in old age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2190456" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Black hairy tongue.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28247090" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Black Hairy Tongue: Predisposing Factors, Diagnosis, and Treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12517366" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Benign migratory glossitis or geographic tongue: an enigmatic oral lesion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1303549" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Symptomatic benign migratory glossitis: report of two cases and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3476662" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Geographic stomatitis: review of the literature and report of five cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21886753" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Geographic tongue treated with topical tacrolimus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21912494" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Median rhomboid glossitis: a clinical and microbiological study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26523164" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : Median rhomboid glossitis-developmental or candidal?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25566575" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : Granular cell tumor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24880452" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : Granular cell tumor of the oral cavity; a case series including a case of metachronous occurrence in the tongue and the lung.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37640402" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : Mucocoele of the lower lip.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20708324" id="rid135" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          136 : Oral mucoceles: a clinicopathologic review of 1,824 cases, including unusual variants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20038883" id="rid136" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          137 : Mucoceles of the oral cavity: a large case series (1994-2008) and a literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31034120" id="rid137" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          138 : World Workshop on Oral Medicine VII: Relative frequency of oral mucosal lesions in children, a scoping review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20594633" id="rid138" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          139 : Clinical characteristics, treatment, and evolution of 89 mucoceles in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17448832" id="rid139" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          140 : Treatment of mucocele of the lower lip with carbon dioxide laser.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27822227" id="rid140" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          141 : Nonsurgical Management of Oral Mucocele by Intralesional Corticosteroid Therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24737369" id="rid141" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          142 : A nodular protuberance on the hard palate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23959969" id="rid142" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          143 : The tori of the mouth and ear: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19767716" id="rid143" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          144 : Current status of the torus palatinus and torus mandibularis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11570546" id="rid144" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          145 : An epidemiological study of tori among 667 dental outpatients in Trinidad&amp;Tobago, West Indies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10884635" id="rid145" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          146 : Buccal and palatal exostoses: prevalence and concurrence with tori.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15119797" id="rid146" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          147 : Epidemiological aspects of oral tori in a Ghanaian community.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28577371" id="rid147" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          148 : Prevalence of Torus Mandibularis in Young Healthy Dentate Adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8097007" id="rid148" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          149 : Gingival sequestration of amlodipine and amlodipine-induced gingival overgrowth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8135450" id="rid149" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          150 : Calcium antagonist-induced gingival hyperplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32508452" id="rid150" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          151 : Relative frequency of oral focal reactive overgrowths: An institutional retrospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21383277" id="rid151" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          152 : Picture of the month. Telangiectases secondary to hereditary hemorrhagic telangiectasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20870325" id="rid152" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          153 : Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28916024" id="rid153" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          154 : Contact stomatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30965061" id="rid154" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          155 : Dermatologic manifestations associated with electronic cigarette use.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
